| (+)-alpha-tocopherol | multiple interactions | EXP | | 6480464 | alpha-Tocopherol inhibits the reaction [Tamoxifen results in increased cleavage of PARP1 protein] | CTD | PMID:14645110 |
| (+)-catechin | multiple interactions | ISO | RGD:1551988 | 6480464 | Catechin inhibits the reaction [tert-Butylhydroperoxide results in increased cleavage of PARP1 protein] | CTD | PMID:16753784 |
| (+)-catechin | increases expression | ISO | RGD:1551988 | 6480464 | Catechin results in increased expression of PARP1 protein | CTD | PMID:16753784 |
| (-)-epigallocatechin 3-gallate | increases cleavage | EXP | | 6480464 | epigallocatechin gallate results in increased cleavage of PARP1 protein | CTD | PMID:15764647 PMID:15705601 |
| (-)-epigallocatechin 3-gallate | multiple interactions | EXP | | 6480464 | epigallocatechin gallate inhibits the reaction [potassium chromate(VI) results in increased cleavage of and results in increased activity of PARP1 protein] | CTD | PMID:22079256 |
| (-)-epigallocatechin 3-gallate | increases cleavage | EXP | | 6480464 | epigallocatechin gallate results in increased cleavage of PARP1 protein | CTD | PMID:15705601 PMID:15764647 |
| (-)-epigallocatechin 3-gallate | increases activity | EXP | | 6480464 | epigallocatechin gallate results in increased activity of PARP1 protein | CTD | PMID:15657356 |
| (-)-selegiline | multiple interactions | ISO | RGD:1551988 | 6480464 | Selegiline inhibits the reaction [3-morpholino-sydnonimine results in decreased expression of PARP1 protein]; more ... | CTD | PMID:12880480 |
| (R)-mevalonic acid | multiple interactions | EXP | | 6480464 | Mevalonic Acid inhibits the reaction [Simvastatin results in increased cleavage of PARP1 protein] | CTD | PMID:20045437 |
| (R)-mevalonic acid | multiple interactions | EXP | | 6480464 | Mevalonic Acid inhibits the reaction [Simvastatin promotes the reaction [TNFSF10 protein results in increased cleavage of PARP1 protein]]; more ... | CTD | PMID:21910007 |
| (S)-nicotine | multiple interactions | EXP | | 6480464 | Nicotine inhibits the reaction [Etoposide results in increased cleavage of PARP1 protein] | CTD | PMID:20457658 |
| (S)-ropivacaine | multiple interactions | EXP | | 6480464 | CLU protein inhibits the reaction [ropivacaine results in increased cleavage of PARP1 protein]; more ... | CTD | PMID:15538973 |
| (S)-ropivacaine | increases cleavage | EXP | | 6480464 | ropivacaine results in increased cleavage of PARP1 protein | CTD | PMID:15538973 |
| 1'-acetoxychavicol acetate | multiple interactions | EXP | | 6480464 | 1'-acetoxychavicol acetate promotes the reaction [TNF protein results in increased cleavage of PARP1 protein] | CTD | PMID:15905586 |
| 1,3-dinitrobenzene | increases cleavage | ISO | RGD:1551988 | 6480464 | 3-dinitrobenzene results in increased cleavage of PARP1 protein | CTD | PMID:19477251 |
| 1,3-dinitrobenzene | multiple interactions | ISO | RGD:1551988 | 6480464 | anthra(1,9-cd)pyrazol-6(2H)-one inhibits the reaction [3-dinitrobenzene results in increased cleavage of PARP1 protein] | CTD | PMID:19477251 |
| 1,4-dithiothreitol | multiple interactions | ISO | RGD:1551988 | 6480464 | Dithiothreitol inhibits the reaction [sodium arsenite results in increased cleavage of PARP1 protein] | CTD | PMID:11035063 |
| 17alpha-ethynylestradiol | multiple interactions | ISO | RGD:1551988 | 6480464 | [Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of PARP1 mRNA | CTD | PMID:17942748 |
| 17beta-estradiol | multiple interactions | EXP | | 6480464 | Estradiol promotes the reaction [PARP1 protein binds to HTR1A promoter mutant form]; more ... | CTD | PMID:21990073 |
| 2,2',4,4',5,5'-hexachlorobiphenyl | increases activity | EXP | | 6480464 | 2,4,5,2',4',5'-hexachlorobiphenyl results in increased activity of PARP1 protein | CTD | PMID:16884709 |
| 2,2',5,5'-tetrachlorobiphenyl | multiple interactions | EXP | | 6480464 | [2,5,2',5'-tetrachlorobiphenyl results in increased activity of PARP1 protein] which results in decreased abundance of NAD | CTD | PMID:19433264 |
| 2,2',5,5'-tetrachlorobiphenyl | increases activity | EXP | | 6480464 | 2,5,2',5'-tetrachlorobiphenyl results in increased activity of PARP1 protein | CTD | PMID:19433264 |
| 2,3,7,8-tetrachlorodibenzodioxine | multiple interactions | EXP | | 6480464 | [3-aminobenzamide results in decreased activity of PARP1 protein] inhibits the reaction [Tetrachlorodibenzodioxin results in decreased abundance of NAD]; more ... | CTD | PMID:17669606 |
| 2,3,7,8-tetrachlorodibenzodioxine | affects expression | EXP | | 6480464 | Tetrachlorodibenzodioxin affects the expression of PARP1 mRNA | CTD | PMID:22574217 |
| 2,3,7,8-tetrachlorodibenzodioxine | affects expression | ISO | RGD:1551988 | 6480464 | Tetrachlorodibenzodioxin affects the expression of PARP1 mRNA | CTD | PMID:21570461 |
| 2,3,7,8-tetrachlorodibenzodioxine | multiple interactions | ISO | RGD:1551988 | 6480464 | Tetrachlorodibenzodioxin promotes the reaction [AHR protein binds to PARP1 promoter] | CTD | PMID:19654925 |
| 2,3,7,8-tetrachlorodibenzodioxine | multiple interactions | ISO | RGD:1551988 | 6480464 | [Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of PARP1 mRNA | CTD | PMID:17942748 |
| 2,3,7,8-tetrachlorodibenzodioxine | increases expression | ISO | RGD:1551988 | 6480464 | Tetrachlorodibenzodioxin results in increased expression of PARP1 mRNA | CTD | PMID:19465110 |
| 2,6-di-tert-butyl-4-methylphenol | multiple interactions | EXP | | 6480464 | Butylated Hydroxytoluene inhibits the reaction [Benzoyl Peroxide results in increased activity of PARP1 protein]; more ... | CTD | PMID:2126186 |
| 2-amino-2-deoxy-D-galactopyranose | multiple interactions | ISO | RGD:1551988 | 6480464 | gentiopicroside inhibits the reaction [[[Galactosamine co-treated with Lipopolysaccharides] results in increased cleavage of and results in increased activity of CASP3 protein] which results in increased cleavage of PARP1 protein] | CTD | PMID:20558151 |
| 2-amino-2-deoxy-D-glucopyranose | increases cleavage | EXP | | 6480464 | Glucosamine results in increased cleavage of PARP1 protein | CTD | PMID:16850161 |
| 2-amino-2-deoxy-D-glucopyranose | multiple interactions | EXP | | 6480464 | pepstatin inhibits the reaction [Glucosamine results in increased cleavage of PARP1 protein] | CTD | PMID:16850161 |
| 2-trans,6-trans,10-trans-geranylgeranyl diphosphate | multiple interactions | EXP | | 6480464 | geranylgeranyl pyrophosphate inhibits the reaction [Simvastatin promotes the reaction [TNFSF10 protein results in increased cleavage of PARP1 protein]]; more ... | CTD | PMID:21910007 |
| 3,3',4,4',5-pentachlorobiphenyl | multiple interactions | EXP | | 6480464 | 3,4,5,3',4'-pentachlorobiphenyl inhibits the reaction [Benzo(a)pyrene results in increased cleavage of PARP1 protein] | CTD | PMID:20840854 |
| 3,3',4,4',5-pentachlorobiphenyl | increases activity | EXP | | 6480464 | 3,4,5,3',4'-pentachlorobiphenyl results in increased activity of PARP1 protein | CTD | PMID:16884709 |
| 3,3',4,4'-tetrachlorobiphenyl | increases activity | EXP | | 6480464 | 3,4,3',4'-tetrachlorobiphenyl results in increased activity of PARP1 protein | CTD | PMID:19433264 |
| 3,3',4,4'-tetrachlorobiphenyl | multiple interactions | EXP | | 6480464 | [3,4,3',4'-tetrachlorobiphenyl results in increased activity of PARP1 protein] which results in decreased abundance of NAD | CTD | PMID:19433264 |
| 3,3'-diindolylmethane | multiple interactions | EXP | | 6480464 | [3,3'-diindolylmethane co-treated with Paclitaxel] results in increased cleavage of and results in increased activity of PARP1 protein | CTD | PMID:16580691 |
| 3,4-methylenedioxymethamphetamine | increases expression | ISO | RGD:1551988 | 6480464 | N-Methyl-3,4-methylenedioxyamphetamine results in increased expression of PARP1 mRNA | CTD | PMID:20188158 |
| 3-aminobenzamide | decreases activity | EXP | | 6480464 | 3-aminobenzamide results in decreased activity of PARP1 protein | CTD | PMID:21370912 more ... |
| 3-aminobenzamide | decreases activity | EXP | | 6480464 | 3-aminobenzamide results in decreased activity of PARP1 protein | CTD | PMID:15670817 more ... |
| 3-aminobenzamide | decreases activity | EXP | | 6480464 | 3-aminobenzamide results in decreased activity of PARP1 protein | CTD | PMID:17669606 more ... |
| 3-aminobenzamide | multiple interactions | EXP | | 6480464 | 3-aminobenzamide inhibits the reaction [Capsaicin results in increased ADP-ribosylation of PARP1 protein modified form]; more ... | CTD | PMID:22226932 |
| 3-aminobenzamide | decreases activity | EXP | | 6480464 | 3-aminobenzamide results in decreased activity of PARP1 protein | CTD | PMID:21399878 more ... |
| 3-aminobenzamide | decreases activity | EXP | | 6480464 | 3-aminobenzamide results in decreased activity of PARP1 protein | CTD | PMID:15670817 more ... |
| 3-aminobenzamide | multiple interactions | EXP | | 6480464 | 3-aminobenzamide inhibits the reaction [Benzoyl Peroxide results in increased activity of PARP1 protein]; more ... | CTD | PMID:2120135 PMID:2126186 |
| 3-aminobenzamide | multiple interactions | EXP | | 6480464 | [3-aminobenzamide results in decreased activity of PARP1 protein] inhibits the reaction [Tetrachlorodibenzodioxin results in decreased abundance of NAD]; more ... | CTD | PMID:17669606 |
| 3-aminobenzamide | multiple interactions | EXP | | 6480464 | 3-aminobenzamide inhibits the reaction [Lithocholic Acid analog results in increased activity of PARP1 protein]; more ... | CTD | PMID:2120135 |
| 3-aminobenzamide | multiple interactions | EXP | | 6480464 | 3-aminobenzamide inhibits the reaction [Benzoyl Peroxide results in increased activity of PARP1 protein]; more ... | CTD | PMID:2126186 PMID:2120135 |
| 3-aminobenzamide | multiple interactions | ISO | RGD:1551988 | 6480464 | 3-aminobenzamide inhibits the reaction [PARP1 protein results in increased susceptibility to Acetaminophen] | CTD | PMID:15601672 |
| 3-aminobenzamide | multiple interactions | EXP | | 6480464 | [3-aminobenzamide results in decreased activity of PARP1 protein] which results in increased susceptibility to Cisplatin | CTD | PMID:21399878 |
| 3-aminobenzamide | decreases activity | EXP | | 6480464 | 3-aminobenzamide results in decreased activity of PARP1 protein | CTD | PMID:15670817 more ... |
| 3-aminobenzamide | decreases activity | EXP | | 6480464 | 3-aminobenzamide results in decreased activity of PARP1 protein | CTD | PMID:17669606 more ... |
| 3-methyladenine | multiple interactions | EXP | | 6480464 | 3-methyladenine promotes the reaction [Flavanones results in increased cleavage of PARP1 protein] | CTD | PMID:21616090 |
| 3-methyladenine | multiple interactions | EXP | | 6480464 | 3-methyladenine promotes the reaction [Fluorouracil results in increased cleavage of and results in increased activity of PARP1 protein] | CTD | PMID:19116755 |
| 3-methyladenine | multiple interactions | ISO | RGD:1551988 | 6480464 | 3-methyladenine promotes the reaction [Fluorouracil results in increased cleavage of and results in increased activity of PARP1 protein] | CTD | PMID:19116755 |
| 3-methyladenine | increases cleavage | EXP | | 6480464 | 3-methyladenine results in increased cleavage of PARP1 protein | CTD | PMID:21616090 |
| 3-methylcholanthrene | multiple interactions | ISO | RGD:2053 | 6480464 | Methylcholanthrene inhibits the reaction [Trp-P-1 results in increased cleavage of PARP1 protein]; more ... | CTD | PMID:11999409 |
| 4,4'-diaminodiphenylmethane | increases expression | ISO | RGD:1551988 | 6480464 | 4,4'-diaminodiphenylmethane results in increased expression of PARP1 mRNA | CTD | PMID:18648102 |
| 4-amino-1,8-naphthalimide | multiple interactions | EXP | | 6480464 | 4-amino-1,8-naphthalimide inhibits the reaction [Doxorubicin results in increased activity of PARP1 protein] | CTD | PMID:15456408 |
| 4-amino-1,8-naphthalimide | multiple interactions | ISO | RGD:1551988 | 6480464 | ATM protein affects the reaction [4-amino-1,8-naphthalimide results in decreased activity of PARP1 protein]; more ... | CTD | PMID:16556909 |
| 4-amino-1,8-naphthalimide | decreases activity | ISO | RGD:1551988 | 6480464 | 4-amino-1,8-naphthalimide results in decreased activity of PARP1 protein | CTD | PMID:16556909 |
| 4-hydroxynon-2-enal | increases degradation | EXP | | 6480464 | 4-hydroxy-2-nonenal results in increased degradation of PARP1 protein | CTD | PMID:11488593 |
| 4-hydroxyphenyl retinamide | multiple interactions | EXP | | 6480464 | anthra(1,9-cd)pyrazol-6(2H)-one inhibits the reaction [Fenretinide results in increased cleavage of PARP1 protein]; more ... | CTD | PMID:16407847 |
| 4-hydroxyphenyl retinamide | increases cleavage | EXP | | 6480464 | Fenretinide results in increased cleavage of PARP1 protein | CTD | PMID:15735044 PMID:16407847 |
| 4-hydroxyphenyl retinamide | increases cleavage | EXP | | 6480464 | Fenretinide results in increased cleavage of PARP1 protein | CTD | PMID:16407847 PMID:15735044 |
| 4-hydroxyphenyl retinamide | multiple interactions | EXP | | 6480464 | Fenretinide promotes the reaction [TNF protein results in increased cleavage of PARP1 protein] | CTD | PMID:16230421 |
| 4-hydroxyphenyl retinamide | decreases cleavage | EXP | | 6480464 | Fenretinide results in decreased cleavage of PARP1 protein | CTD | PMID:17159502 |
| 4-hydroxyphenyl retinamide | multiple interactions | EXP | | 6480464 | [Fenretinide co-treated with TNFSF10 protein] results in increased cleavage of PARP1 protein | CTD | PMID:17273769 |
| 4-hydroxyphenyl retinamide | affects expression | EXP | | 6480464 | Fenretinide affects the expression of PARP1 mRNA | CTD | PMID:16570282 |
| 5-aminolevulinic acid | multiple interactions | EXP | | 6480464 | FADD mutant form inhibits the reaction [Aminolevulinic Acid analog results in increased cleavage of PARP1 protein] | CTD | PMID:21138480 |
| 5-aminolevulinic acid | increases cleavage | EXP | | 6480464 | Aminolevulinic Acid analog results in increased cleavage of PARP1 protein | CTD | PMID:21138480 |
| 5-aza-2'-deoxycytidine | multiple interactions | EXP | | 6480464 | [decitabine co-treated with TNFSF10 protein] results in increased cleavage of PARP1 protein | CTD | PMID:18636160 |
| 5-aza-2'-deoxycytidine | decreases methylation | EXP | | 6480464 | decitabine results in decreased methylation of PARP1 gene | CTD | PMID:20123007 |
| 5-aza-2'-deoxycytidine | multiple interactions | EXP | | 6480464 | decitabine inhibits the reaction [Benzene results in increased methylation of PARP1 promoter]; more ... | CTD | PMID:20230882 |
| 5-aza-2'-deoxycytidine | multiple interactions | EXP | | 6480464 | decitabine inhibits the reaction [Silicon Dioxide results in decreased expression of PARP1 mRNA] | CTD | PMID:20123007 |
| 5-aza-2'-deoxycytidine | multiple interactions | EXP | | 6480464 | [decitabine co-treated with Busulfan] results in increased cleavage of PARP1 protein; more ... | CTD | PMID:19732952 |
| 5-fluoro-2'-deoxyuridine | decreases response to substance | EXP | | 6480464 | PARP1 protein results in decreased susceptibility to Floxuridine | CTD | PMID:21613406 |
| 5-fluorouracil | multiple interactions | EXP | | 6480464 | 3-methyladenine promotes the reaction [Fluorouracil results in increased cleavage of and results in increased activity of PARP1 protein] | CTD | PMID:19116755 |
| 5-fluorouracil | increases cleavage | EXP | | 6480464 | Fluorouracil results in increased cleavage of PARP1 protein | CTD | PMID:15996812 more ... |
| 5-fluorouracil | increases cleavage | EXP | | 6480464 | Fluorouracil results in increased cleavage of PARP1 protein | CTD | PMID:19816940 more ... |
| 5-fluorouracil | increases cleavage | EXP | | 6480464 | Fluorouracil results in increased cleavage of PARP1 protein | CTD | PMID:17982676 more ... |
| 5-fluorouracil | increases cleavage | EXP | | 6480464 | Fluorouracil results in increased cleavage of PARP1 protein | CTD | PMID:15996812 more ... |
| 5-fluorouracil | increases cleavage | EXP | | 6480464 | Fluorouracil results in increased cleavage of PARP1 protein | CTD | PMID:16525653 more ... |
| 5-fluorouracil | increases cleavage | EXP | | 6480464 | Fluorouracil results in increased cleavage of PARP1 protein | CTD | PMID:16525653 more ... |
| 5-fluorouracil | multiple interactions | EXP | | 6480464 | TP53 protein promotes the reaction [Fluorouracil results in increased cleavage of PARP1 protein] | CTD | PMID:17982676 |
| 5-fluorouracil | multiple interactions | ISO | RGD:1551988 | 6480464 | 3-methyladenine promotes the reaction [Fluorouracil results in increased cleavage of and results in increased activity of PARP1 protein] | CTD | PMID:19116755 |
| 5-fluorouracil | increases expression | EXP | | 6480464 | Fluorouracil results in increased expression of PARP1 | CTD | PMID:11300326 |
| 5-fluorouracil | increases cleavage | EXP | | 6480464 | Fluorouracil results in increased cleavage of PARP1 protein | CTD | PMID:17461495 more ... |
| 5-fluorouracil | multiple interactions | EXP | | 6480464 | Fluorouracil promotes the reaction [gambogic acid results in increased cleavage of PARP1 protein]; more ... | CTD | PMID:19084572 |
| 5-fluorouracil | multiple interactions | EXP | | 6480464 | [Fluorouracil co-treated with Genistein] results in increased cleavage of PARP1 protein | CTD | PMID:15896711 |
| 5-fluorouracil | multiple interactions | EXP | | 6480464 | celecoxib inhibits the reaction [Fluorouracil results in increased cleavage of PARP1 protein] | CTD | PMID:17461495 |
| 9-cis-retinoic acid | increases cleavage | EXP | | 6480464 | alitretinoin results in increased cleavage of PARP1 protein | CTD | PMID:16449964 |
| acenaphthylene | increases cleavage | EXP | | 6480464 | acenaphthylene results in increased cleavage of PARP1 protein | CTD | PMID:21132278 |
| acetylsalicylic acid | increases cleavage | EXP | | 6480464 | Aspirin results in increased cleavage of PARP1 protein | CTD | PMID:9694730 more ... |
| acetylsalicylic acid | increases cleavage | EXP | | 6480464 | Aspirin results in increased cleavage of PARP1 protein | CTD | PMID:11228543 more ... |
| acetylsalicylic acid | increases cleavage | EXP | | 6480464 | Aspirin results in increased cleavage of PARP1 protein | CTD | PMID:11532860 more ... |
| acetylsalicylic acid | increases cleavage | EXP | | 6480464 | Aspirin results in increased cleavage of PARP1 protein | CTD | PMID:9694730 more ... |
| acetylsalicylic acid | multiple interactions | EXP | | 6480464 | Aspirin inhibits the reaction [Deoxycholic Acid results in increased cleavage of PARP1 protein] | CTD | PMID:17644113 |
| acetylsalicylic acid | increases cleavage | EXP | | 6480464 | Aspirin results in increased cleavage of PARP1 protein | CTD | PMID:9694730 more ... |
| acetylsalicylic acid | multiple interactions | EXP | | 6480464 | Aspirin promotes the reaction [troglitazone results in increased cleavage of PARP1 protein]; more ... | CTD | PMID:19908241 |
| acetylsalicylic acid | multiple interactions | EXP | | 6480464 | Aspirin promotes the reaction [TNFSF10 protein results in increased cleavage of PARP1 protein]; more ... | CTD | PMID:16199534 |
| acetylsalicylic acid | multiple interactions | EXP | | 6480464 | Aspirin results in increased cleavage of and results in increased activity of PARP1 protein | CTD | PMID:15481331 |
| acetylsalicylic acid | multiple interactions | EXP | | 6480464 | [Aspirin co-treated with TNFSF10 protein] results in increased cleavage of PARP1 protein | CTD | PMID:18483385 |
| acetylsalicylic acid | increases cleavage | EXP | | 6480464 | Aspirin results in increased cleavage of PARP1 protein | CTD | PMID:9694730 more ... |
| acrolein | increases cleavage | EXP | | 6480464 | Acrolein results in increased cleavage of PARP1 protein | CTD | PMID:19596284 |
| actinomycin D | multiple interactions | EXP | | 6480464 | Dactinomycin promotes the reaction [TNF results in increased cleavage of PARP1 protein]; more ... | CTD | PMID:16492401 |
| actinomycin D | multiple interactions | ISO | RGD:1551988 | 6480464 | PLD2 protein inhibits the reaction [Dactinomycin results in increased cleavage of PARP1 protein] | CTD | PMID:14640974 |
| actinomycin D | multiple interactions | EXP | | 6480464 | PLD1 protein inhibits the reaction [Dactinomycin results in increased cleavage of PARP1 protein] | CTD | PMID:14640974 |
| aflatoxin B1 | increases expression | ISO | RGD:1551988 | 6480464 | Aflatoxin B1 results in increased expression of PARP1 mRNA | CTD | PMID:19770486 |
| alantolactone | increases cleavage | EXP | | 6480464 | alantolactone results in increased cleavage of PARP1 protein | CTD | PMID:22721982 |
| aldehydo-D-glucosamine | increases cleavage | EXP | | 6480464 | Glucosamine results in increased cleavage of PARP1 protein | CTD | PMID:16850161 |
| aldehydo-D-glucosamine | multiple interactions | EXP | | 6480464 | pepstatin inhibits the reaction [Glucosamine results in increased cleavage of PARP1 protein] | CTD | PMID:16850161 |
| all-trans-acitretin | increases activity | EXP | | 6480464 | Acitretin results in increased activity of PARP1 protein | CTD | PMID:18624760 |
| all-trans-retinoic acid | multiple interactions | EXP | | 6480464 | [IFNB1 protein co-treated with Tretinoin] results in increased cleavage of PARP1 protein | CTD | PMID:16826196 |
| all-trans-retinoic acid | multiple interactions | ISO | RGD:1551988 | 6480464 | Tretinoin promotes the reaction [((1S,2S,4R)-4-(4-((1S)-2,3-dihydro-1H-inden-1-ylamino)-7H-pyrrolo(2,3-d)pyrimidin-7-yl)-2-hydroxycyclopentyl)methyl sulphamate results in increased cleavage of and results in increased activity of PARP1 protein] | CTD | PMID:22110742 |
| all-trans-retinoic acid | increases cleavage | EXP | | 6480464 | Tretinoin results in increased cleavage of PARP1 protein | CTD | PMID:17387344 PMID:14519626 |
| all-trans-retinoic acid | multiple interactions | EXP | | 6480464 | Tretinoin inhibits the reaction [geldanamycin results in increased degradation of PARP1 protein] | CTD | PMID:17293044 |
| all-trans-retinoic acid | increases cleavage | EXP | | 6480464 | Tretinoin results in increased cleavage of PARP1 protein | CTD | PMID:14519626 PMID:17387344 |
| alprazolam | multiple interactions | EXP | | 6480464 | [Caffeine co-treated with Alprazolam] results in increased activity of PARP1 protein | CTD | PMID:19490937 |
| amiloride | multiple interactions | EXP | | 6480464 | Amiloride promotes the reaction [TNFSF10 protein results in increased cleavage of PARP1 protein] | CTD | PMID:15607733 PMID:16059913 |
| amiloride | multiple interactions | EXP | | 6480464 | Amiloride promotes the reaction [TNFSF10 protein results in increased cleavage of PARP1 protein] | CTD | PMID:16059913 PMID:15607733 |
| amiloride | multiple interactions | EXP | | 6480464 | Okadaic Acid inhibits the reaction [Amiloride promotes the reaction [TNFSF10 protein results in increased cleavage of PARP1 protein]] | CTD | PMID:16059913 |
| amiodarone | multiple interactions | EXP | | 6480464 | [TNFSF10 co-treated with Amiodarone] results in increased cleavage of PARP1 protein | CTD | PMID:21292685 |
| ammonia | affects response to substance | ISO | RGD:2053 | 6480464 | PARP1 protein affects the susceptibility to Ammonia | CTD | PMID:15147502 |
| ammonium acetate | multiple interactions | ISO | RGD:2053 | 6480464 | Cycloheximide inhibits the reaction [ammonium acetate results in increased expression of PARP1 protein]; more ... | CTD | PMID:15147502 |
| ammonium acetate | increases expression | ISO | RGD:2053 | 6480464 | ammonium acetate results in increased expression of PARP1 protein | CTD | PMID:15147502 |
| ammonium chloride | multiple interactions | ISO | RGD:2053 | 6480464 | (1,2,5,6-tetrahydropyridin-4-yl)methylphosphinic acid inhibits the reaction [4-aminocrotonic acid inhibits the reaction [Ammonium Chloride results in increased cleavage of PARP1 protein]] | CTD | PMID:14535961 |
| ammonium chloride | affects expression | ISO | RGD:2053 | 6480464 | Ammonium Chloride affects the expression of PARP1 mRNA | CTD | PMID:16483693 |
| ammonium chloride | increases cleavage | ISO | RGD:2053 | 6480464 | Ammonium Chloride results in increased cleavage of PARP1 protein | CTD | PMID:14535961 |
| antimycin A | increases cleavage | EXP | | 6480464 | Antimycin A results in increased cleavage of PARP1 protein | CTD | PMID:16237197 |
| antimycin A | multiple interactions | EXP | | 6480464 | [Antimycin A co-treated with Paraquat] results in increased cleavage of PARP1 protein | CTD | PMID:16237197 |
| apigenin | multiple interactions | ISO | RGD:1551988 | 6480464 | Apigenin inhibits the reaction [Brefeldin A results in increased cleavage of PARP1 protein]; more ... | CTD | PMID:20493918 |
| apigenin | multiple interactions | ISO | RGD:1551988 | 6480464 | Apigenin inhibits the reaction [Cyclosporine results in increased cleavage of PARP1 protein] | CTD | PMID:22155090 |
| apocynin | multiple interactions | ISO | RGD:1551988 | 6480464 | acetovanillone inhibits the reaction [zinc chloride results in increased activity of PARP1 protein] | CTD | PMID:18509044 |
| arachidonic acid | multiple interactions | EXP | | 6480464 | 1,2-bis(2-aminophenoxy)ethane N,N,N',N'-tetraacetic acid acetoxymethyl ester inhibits the reaction [Arachidonic Acid results in increased cleavage of PARP1 protein] | CTD | PMID:19540902 |
| arachidonic acid | increases cleavage | EXP | | 6480464 | Arachidonic Acid results in increased cleavage of PARP1 protein | CTD | PMID:19540902 PMID:21132278 |
| arachidonic acid | increases cleavage | EXP | | 6480464 | Arachidonic Acid results in increased cleavage of PARP1 protein | CTD | PMID:21132278 |
| arachidonic acid | increases cleavage | EXP | | 6480464 | Arachidonic Acid results in increased cleavage of PARP1 protein | CTD | PMID:21132278 PMID:19540902 |
| arsenic atom | decreases expression | EXP | | 6480464 | Arsenic results in decreased expression of PARP1 mRNA; more ... | CTD | PMID:21332098 |
| arsenic atom | multiple interactions | EXP | | 6480464 | Curcumin inhibits the reaction [Arsenic results in decreased expression of PARP1 mRNA]; more ... | CTD | PMID:21332098 |
| arsenite(3-) | increases cleavage | EXP | | 6480464 | arsenite results in increased cleavage of PARP1 protein | CTD | PMID:20083129 |
| arsenite(3-) | increases expression | EXP | | 6480464 | arsenite results in increased expression of PARP1 protein | CTD | PMID:18392098 |
| arsenite(3-) | multiple interactions | EXP | | 6480464 | Curcumin promotes the reaction [arsenite results in increased expression of PARP1 protein] | CTD | PMID:18392098 |
| arsenite(3-) | multiple interactions | EXP | | 6480464 | Zinc inhibits the reaction [arsenite results in decreased activity of PARP1 protein] | CTD | PMID:18707137 |
| arsenite(3-) | multiple interactions | EXP | | 6480464 | TP53 mutant form inhibits the reaction [arsenite results in increased cleavage of PARP1 protein] | CTD | PMID:22260869 |
| arsenite(3-) | increases cleavage | EXP | | 6480464 | arsenite results in increased cleavage of PARP1 protein | CTD | PMID:20083129 PMID:22260869 |
| arsenite(3-) | decreases activity | EXP | | 6480464 | arsenite results in decreased activity of PARP1 protein | CTD | PMID:17011244 more ... |
| arsenite(3-) | affects response to substance | EXP | | 6480464 | PARP1 protein affects the susceptibility to arsenite | CTD | PMID:22387748 |
| arsenite(3-) | decreases cleavage | EXP | | 6480464 | arsenite results in decreased cleavage of PARP1 protein | CTD | PMID:22387748 |
| arsenite(3-) | decreases activity | EXP | | 6480464 | arsenite results in decreased activity of PARP1 protein | CTD | PMID:17011244 PMID:22387748 |
| arsenite(3-) | multiple interactions | EXP | | 6480464 | [arsenite results in decreased activity of PARP1 protein] which affects the localization of AIFM1 protein; more ... | CTD | PMID:22387748 |
| arsenite(3-) | decreases activity | EXP | | 6480464 | arsenite results in decreased activity of PARP1 protein | CTD | PMID:17011244 |
| ATP | increases expression | ISO | RGD:1551988 | 6480464 | Adenosine Triphosphate results in increased expression of PARP1 protein | CTD | PMID:22253048 |
| ATP | multiple interactions | ISO | RGD:1551988 | 6480464 | PARP1 protein affects the reaction [pyrithione zinc results in decreased abundance of Adenosine Triphosphate] | CTD | PMID:19809895 |
| ATP | multiple interactions | EXP | | 6480464 | PARP1 mutant form inhibits the reaction [Cadmium results in decreased abundance of Adenosine Triphosphate] | CTD | PMID:21767558 |
| ATP | multiple interactions | ISO | RGD:1551988 | 6480464 | PARP1 protein affects the reaction [Zinc results in decreased abundance of Adenosine Triphosphate] | CTD | PMID:17728843 |
| auranofin | decreases activity | EXP | | 6480464 | Auranofin results in decreased activity of PARP1 protein | CTD | PMID:21370912 |
| auranofin | increases cleavage | EXP | | 6480464 | Auranofin results in increased cleavage of PARP1 protein | CTD | PMID:15159275 |
| bafilomycin A1 | multiple interactions | EXP | | 6480464 | bafilomycin A1 promotes the reaction [atorvastatin results in increased cleavage of PARP1 protein] | CTD | PMID:20876807 |
| bafilomycin A1 | increases cleavage | EXP | | 6480464 | bafilomycin A1 results in increased cleavage of PARP1 protein | CTD | PMID:21616090 |
| bafilomycin A1 | multiple interactions | EXP | | 6480464 | bafilomycin A1 promotes the reaction [Flavanones results in increased cleavage of PARP1 protein] | CTD | PMID:21616090 |
| benomyl | increases cleavage | EXP | | 6480464 | Benomyl results in increased cleavage of PARP1 protein | CTD | PMID:16903866 |
| benzene | increases cleavage | EXP | | 6480464 | Benzene analog results in increased cleavage of PARP1 protein | CTD | PMID:15826604 |
| benzene | increases methylation | EXP | | 6480464 | Benzene results in increased methylation of PARP1 promoter | CTD | PMID:20230882 |
| benzene | multiple interactions | EXP | | 6480464 | decitabine inhibits the reaction [Benzene results in decreased expression of PARP1 mRNA]; more ... | CTD | PMID:20230882 |
| benzene | decreases expression | EXP | | 6480464 | Benzene results in decreased expression of PARP1 mRNA | CTD | PMID:20230882 |
| benzo[a]pyrene | multiple interactions | ISO | RGD:1551988 | 6480464 | Benzo(a)pyrene promotes the reaction [AHR protein binds to PARP1 promoter] | CTD | PMID:19654925 |
| benzo[a]pyrene | increases cleavage | EXP | | 6480464 | Benzo(a)pyrene results in increased cleavage of PARP1 protein | CTD | PMID:20840854 |
| benzo[a]pyrene | multiple interactions | EXP | | 6480464 | 2,4,5,2',5'-pentachlorobiphenyl inhibits the reaction [Benzo(a)pyrene results in increased cleavage of PARP1 protein]; more ... | CTD | PMID:20840854 |
| benzo[a]pyrene | increases cleavage | ISO | RGD:1551988 | 6480464 | Benzo(a)pyrene results in increased cleavage of PARP1 protein | CTD | PMID:19041363 |
| benzo[a]pyrene | decreases expression | ISO | RGD:1551988 | 6480464 | Benzo(a)pyrene results in decreased expression of PARP1 mRNA | CTD | PMID:19770486 |
| benzo[a]pyrene | decreases response to substance | EXP | | 6480464 | PARP1 protein results in decreased susceptibility to Benzo(a)pyrene | CTD | PMID:19247804 |
| benzo[a]pyrene | decreases expression | EXP | | 6480464 | Benzo(a)pyrene results in decreased expression of PARP1 mRNA | CTD | PMID:20064835 |
| benzo[b]fluoranthene | increases cleavage | EXP | | 6480464 | benzo(b)fluoranthene results in increased cleavage of PARP1 protein | CTD | PMID:21132278 |
| berberine | increases cleavage | EXP | | 6480464 | Berberine results in increased cleavage of PARP1 protein | CTD | PMID:16505103 |
| beta-cyclodextrin | multiple interactions | ISO | RGD:1551988 | 6480464 | betadex inhibits the reaction [sodium arsenite results in increased cleavage of PARP1 protein] | CTD | PMID:11035063 |
| beta-D-glucosamine | increases cleavage | EXP | | 6480464 | Glucosamine results in increased cleavage of PARP1 protein | CTD | PMID:16850161 |
| beta-D-glucosamine | multiple interactions | EXP | | 6480464 | pepstatin inhibits the reaction [Glucosamine results in increased cleavage of PARP1 protein] | CTD | PMID:16850161 |
| biochanin A | increases cleavage | EXP | | 6480464 | biochanin A results in increased cleavage of PARP1 protein | CTD | PMID:12791511 |
| bis(2-chloroethyl) sulfide | multiple interactions | EXP | | 6480464 | acetyl-aspartyl-glutamyl-valyl-aspartal inhibits the reaction [Mustard Gas results in increased cleavage of PARP1 protein]; more ... | CTD | PMID:12482751 |
| bis(2-chloroethyl) sulfide | increases cleavage | ISO | RGD:2053 | 6480464 | Mustard Gas results in increased cleavage of PARP1 protein | CTD | PMID:20659490 |
| bis(2-chloroethyl) sulfide | increases cleavage | EXP | | 6480464 | Mustard Gas results in increased cleavage of PARP1 protein | CTD | PMID:11886524 more ... |
| bis(2-chloroethyl) sulfide | multiple interactions | EXP | | 6480464 | BRCA2 protein inhibits the reaction [Mustard Gas results in increased cleavage of PARP1 protein] | CTD | PMID:20435105 |
| bis(2-chloroethyl) sulfide | increases cleavage | EXP | | 6480464 | Mustard Gas results in increased cleavage of PARP1 protein | CTD | PMID:12482751 more ... |
| bis(2-chloroethyl) sulfide | increases cleavage | EXP | | 6480464 | Mustard Gas results in increased cleavage of PARP1 protein | CTD | PMID:17229443 more ... |
| bis(2-chloroethyl) sulfide | increases cleavage | EXP | | 6480464 | Mustard Gas results in increased cleavage of PARP1 protein | CTD | PMID:12482751 more ... |
| bis(2-chloroethyl) sulfide | multiple interactions | ISO | RGD:1551988 | 6480464 | PARP1 protein inhibits the reaction [Mustard Gas results in increased activity of CASP3 protein] | CTD | PMID:11886524 |
| bis(2-chloroethyl) sulfide | multiple interactions | EXP | | 6480464 | PARP1 protein affects the reaction [Mustard Gas affects the activity of CASP3 protein] | CTD | PMID:11886524 |
| bis(2-chloroethyl) sulfide | increases cleavage | EXP | | 6480464 | Mustard Gas results in increased cleavage of PARP1 protein | CTD | PMID:11886524 more ... |
| bis(2-chloroethyl) sulfide | multiple interactions | EXP | | 6480464 | CALM1 protein promotes the reaction [Mustard Gas results in increased cleavage of and results in increased activity of PARP1 protein] | CTD | PMID:16935404 |
| bleomycin A2 | increases expression | ISO | RGD:1551988 | 6480464 | Bleomycin results in increased expression of PARP1 protein | CTD | PMID:16317386 |
| bleomycin A2 | increases cleavage | ISO | RGD:2053 | 6480464 | Bleomycin results in increased cleavage of PARP1 protein | CTD | PMID:15371238 |
| brefeldin A | multiple interactions | ISO | RGD:1551988 | 6480464 | Apigenin inhibits the reaction [Brefeldin A results in increased cleavage of PARP1 protein] | CTD | PMID:20493918 |
| brefeldin A | increases cleavage | ISO | RGD:1551988 | 6480464 | Brefeldin A results in increased cleavage of PARP1 protein | CTD | PMID:20493918 |
| busulfan | multiple interactions | EXP | | 6480464 | [clofarabine co-treated with fludarabine co-treated with Busulfan] results in increased cleavage of PARP1 protein | CTD | PMID:20933509 |
| busulfan | multiple interactions | EXP | | 6480464 | [decitabine co-treated with Busulfan] results in increased cleavage of PARP1 protein; more ... | CTD | PMID:19732952 |
| busulfan | increases cleavage | EXP | | 6480464 | Busulfan results in increased cleavage of PARP1 protein | CTD | PMID:18339423 |
| cadmium atom | increases cleavage | ISO | RGD:2053 | 6480464 | Cadmium results in increased cleavage of PARP1 protein | CTD | PMID:19433269 |
| cadmium atom | multiple interactions | EXP | | 6480464 | PARP1 mutant form inhibits the reaction [Cadmium results in decreased abundance of Adenosine Triphosphate] | CTD | PMID:21767558 |
| cadmium atom | multiple interactions | ISO | RGD:2053 | 6480464 | Ascorbic Acid inhibits the reaction [Cadmium results in increased cleavage of PARP1 protein] | CTD | PMID:19433269 |
| cadmium dichloride | multiple interactions | ISO | RGD:1551988 | 6480464 | arjunolic acid inhibits the reaction [Cadmium Chloride results in increased cleavage of PARP1 protein] | CTD | PMID:21420465 |
| cadmium dichloride | increases cleavage | EXP | | 6480464 | Cadmium Chloride results in increased cleavage of PARP1 protein | CTD | PMID:21544200 more ... |
| cadmium dichloride | increases cleavage | ISO | RGD:1551988 | 6480464 | Cadmium Chloride results in increased cleavage of PARP1 protein | CTD | PMID:21420465 PMID:18850067 |
| cadmium dichloride | affects cleavage | ISO | RGD:1551988 | 6480464 | Cadmium Chloride affects the cleavage of PARP1 protein | CTD | PMID:18506790 |
| cadmium dichloride | multiple interactions | ISO | RGD:1551988 | 6480464 | 1,2-bis(2-aminophenoxy)ethane N,N,N',N'-tetraacetic acid acetoxymethyl ester inhibits the reaction [Cadmium Chloride results in increased cleavage of PARP1 protein] | CTD | PMID:18850067 |
| cadmium dichloride | multiple interactions | EXP | | 6480464 | salubrinal inhibits the reaction [Cadmium Chloride results in increased cleavage of PARP1 protein] | CTD | PMID:21809093 |
| cadmium dichloride | multiple interactions | EXP | | 6480464 | 1,2-bis(2-aminophenoxy)ethane N,N,N',N'-tetraacetic acid acetoxymethyl ester inhibits the reaction [Cadmium Chloride results in increased cleavage of PARP1 protein]; more ... | CTD | PMID:21544200 |
| cadmium dichloride | increases cleavage | ISO | RGD:1551988 | 6480464 | Cadmium Chloride results in increased cleavage of PARP1 protein | CTD | PMID:18850067 PMID:21420465 |
| cadmium dichloride | increases cleavage | EXP | | 6480464 | Cadmium Chloride results in increased cleavage of PARP1 protein | CTD | PMID:21544200 more ... |
| cadmium dichloride | increases cleavage | ISO | RGD:2053 | 6480464 | Cadmium Chloride results in increased cleavage of PARP1 protein | CTD | PMID:21544200 |
| cadmium dichloride | multiple interactions | ISO | RGD:2053 | 6480464 | Cadmium Chloride results in increased cleavage of and results in increased activity of PARP1 protein; more ... | CTD | PMID:18703135 |
| cadmium dichloride | multiple interactions | ISO | RGD:2053 | 6480464 | 1,2-bis(2-aminophenoxy)ethane N,N,N',N'-tetraacetic acid acetoxymethyl ester inhibits the reaction [Cadmium Chloride results in increased cleavage of PARP1 protein]; more ... | CTD | PMID:21544200 |
| cadmium dichloride | multiple interactions | EXP | | 6480464 | BIX 02189 promotes the reaction [Cadmium Chloride results in increased cleavage of PARP1 protein] | CTD | PMID:22521884 |
| cadmium dichloride | increases cleavage | EXP | | 6480464 | Cadmium Chloride results in increased cleavage of PARP1 protein | CTD | PMID:22521884 more ... |
| cadmium dichloride | multiple interactions | EXP | | 6480464 | Acetylcysteine inhibits the reaction [Cadmium Chloride results in increased cleavage of and results in increased activity of PARP1 protein] | CTD | PMID:18703135 |
| cadmium dichloride | increases cleavage | ISO | RGD:1551988 | 6480464 | Cadmium Chloride results in increased cleavage of PARP1 protein | CTD | PMID:21420465 |
| cadmium sulfate | multiple interactions | ISO | RGD:1551988 | 6480464 | 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [cadmium sulfate results in increased cleavage of PARP1 protein]; more ... | CTD | PMID:14687664 |
| cadmium sulfate | increases cleavage | ISO | RGD:1551988 | 6480464 | cadmium sulfate results in increased cleavage of PARP1 protein | CTD | PMID:14687664 |
| caffeine | multiple interactions | EXP | | 6480464 | Caffeine promotes the reaction [Capsaicin results in increased cleavage of and results in increased activity of PARP1 protein] | CTD | PMID:22226932 |
| caffeine | increases cleavage | EXP | | 6480464 | Caffeine results in increased cleavage of PARP1 protein | CTD | PMID:21229324 |
| caffeine | multiple interactions | EXP | | 6480464 | Caffeine results in increased cleavage of and results in increased expression of PARP1 protein | CTD | PMID:16522534 |
| caffeine | affects cleavage | EXP | | 6480464 | Caffeine affects the cleavage of PARP1 protein | CTD | PMID:19242509 |
| caffeine | multiple interactions | EXP | | 6480464 | [Caffeine co-treated with Alprazolam] results in increased activity of PARP1 protein | CTD | PMID:19490937 |
| calciol | affects expression | EXP | | 6480464 | Cholecalciferol affects the expression of PARP1 protein | CTD | PMID:18628207 |
| calcium atom | multiple interactions | ISO | RGD:1551988 | 6480464 | PARP1 protein promotes the reaction [Hydrogen Peroxide results in increased uptake of Calcium] | CTD | PMID:20878536 |
| calcium(0) | multiple interactions | ISO | RGD:1551988 | 6480464 | PARP1 protein promotes the reaction [Hydrogen Peroxide results in increased uptake of Calcium] | CTD | PMID:20878536 |
| camptothecin | increases cleavage | EXP | | 6480464 | Camptothecin results in increased cleavage of PARP1 protein | CTD | PMID:15585644 more ... |
| camptothecin | increases cleavage | EXP | | 6480464 | Camptothecin results in increased cleavage of PARP1 protein | CTD | PMID:11741290 more ... |
| camptothecin | increases cleavage | EXP | | 6480464 | Camptothecin results in increased cleavage of PARP1 protein | CTD | PMID:11741290 more ... |
| camptothecin | increases cleavage | ISO | RGD:1551988 | 6480464 | Camptothecin results in increased cleavage of PARP1 protein | CTD | PMID:18506790 |
| camptothecin | increases cleavage | EXP | | 6480464 | Camptothecin results in increased cleavage of PARP1 protein | CTD | PMID:16962673 more ... |
| camptothecin | increases cleavage | EXP | | 6480464 | Camptothecin results in increased cleavage of PARP1 protein | CTD | PMID:16962673 more ... |
| camptothecin | multiple interactions | ISO | RGD:1551988 | 6480464 | [2-((R)-2-methylpyrrolidin-2-yl)-1H-benzimidazole-4-carboxamide results in decreased activity of PARP1 protein] which results in increased susceptibility to Camptothecin | CTD | PMID:22158865 |
| camptothecin | increases cleavage | EXP | | 6480464 | Camptothecin results in increased cleavage of PARP1 protein | CTD | PMID:11741290 more ... |
| camptothecin | multiple interactions | EXP | | 6480464 | RBL2 protein inhibits the reaction [Camptothecin results in increased cleavage of PARP1 protein] | CTD | PMID:15585644 |
| camptothecin | multiple interactions | EXP | | 6480464 | THBS1 protein inhibits the reaction [Camptothecin results in increased cleavage of PARP1 protein] | CTD | PMID:16962673 |
| camptothecin | increases cleavage | EXP | | 6480464 | Camptothecin results in increased cleavage of PARP1 protein | CTD | PMID:15585644 more ... |
| capsaicin | multiple interactions | EXP | | 6480464 | 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one promotes the reaction [Capsaicin results in increased cleavage of and results in increased activity of PARP1 protein]; more ... | CTD | PMID:22226932 |
| capsaicin | increases cleavage | EXP | | 6480464 | Capsaicin results in increased cleavage of PARP1 protein | CTD | PMID:19855437 PMID:17505005 |
| capsaicin | increases cleavage | ISO | RGD:1551988 | 6480464 | Capsaicin results in increased cleavage of PARP1 protein | CTD | PMID:17295509 |
| capsaicin | increases cleavage | EXP | | 6480464 | Capsaicin results in increased cleavage of PARP1 protein | CTD | PMID:17505005 |
| capsaicin | increases expression | EXP | | 6480464 | Capsaicin results in increased expression of PARP1 protein | CTD | PMID:22226932 |
| capsaicin | increases cleavage | EXP | | 6480464 | Capsaicin results in increased cleavage of PARP1 protein | CTD | PMID:17505005 PMID:19855437 |
| capsaicin | increases ADP-ribosylation | EXP | | 6480464 | Capsaicin results in increased ADP-ribosylation of PARP1 protein modified form | CTD | PMID:22226932 |
| capsaicin | multiple interactions | EXP | | 6480464 | Capsaicin promotes the reaction [TNFSF10 results in increased cleavage of PARP1 protein] | CTD | PMID:22200406 |
| carboplatin | increases cleavage | EXP | | 6480464 | Carboplatin results in increased cleavage of PARP1 protein | CTD | PMID:15996812 |
| CDP-choline | decreases expression | EXP | | 6480464 | Cytidine Diphosphate Choline results in decreased expression of PARP1 protein modified form | CTD | PMID:12443983 |
| celastrol | multiple interactions | EXP | | 6480464 | TNFRSF10B protein promotes the reaction [[TNFSF10 protein co-treated with tripterine] results in increased cleavage of PARP1 protein]; more ... | CTD | PMID:20605676 |
| celecoxib | increases cleavage | EXP | | 6480464 | celecoxib results in increased cleavage of PARP1 protein | CTD | PMID:15911099 more ... |
| celecoxib | increases cleavage | EXP | | 6480464 | celecoxib results in increased cleavage of PARP1 protein | CTD | PMID:15572759 more ... |
| celecoxib | increases cleavage | EXP | | 6480464 | celecoxib results in increased cleavage of PARP1 protein | CTD | PMID:19665451 more ... |
| celecoxib | increases cleavage | EXP | | 6480464 | celecoxib results in increased cleavage of PARP1 protein | CTD | PMID:18485224 more ... |
| celecoxib | increases cleavage | EXP | | 6480464 | celecoxib results in increased cleavage of PARP1 protein | CTD | PMID:15572759 more ... |
| celecoxib | increases cleavage | EXP | | 6480464 | celecoxib results in increased cleavage of PARP1 protein | CTD | PMID:18485224 more ... |
| celecoxib | multiple interactions | ISO | RGD:1551988 | 6480464 | celecoxib promotes the reaction [Dihematoporphyrin Ether results in increased cleavage of PARP1 protein] | CTD | PMID:16230411 |
| celecoxib | multiple interactions | EXP | | 6480464 | TNFRSF10B mutant form inhibits the reaction [celecoxib results in increased cleavage of PARP1 protein]; more ... | CTD | PMID:15572759 |
| celecoxib | increases activity | EXP | | 6480464 | celecoxib results in increased activity of PARP1 protein | CTD | PMID:12824303 |
| celecoxib | increases cleavage | EXP | | 6480464 | celecoxib results in increased cleavage of PARP1 protein | CTD | PMID:19665451 more ... |
| celecoxib | multiple interactions | EXP | | 6480464 | celecoxib promotes the reaction [docetaxel results in increased cleavage of and results in increased expression of PARP1 protein]; more ... | CTD | PMID:15688368 |
| celecoxib | multiple interactions | EXP | | 6480464 | celecoxib inhibits the reaction [Fluorouracil results in increased cleavage of PARP1 protein] | CTD | PMID:17461495 |
| celecoxib | affects cleavage | EXP | | 6480464 | celecoxib analog affects the cleavage of PARP1 protein | CTD | PMID:18485224 |
| celecoxib | multiple interactions | EXP | | 6480464 | [atorvastatin co-treated with celecoxib] results in increased cleavage of PARP1 protein | CTD | PMID:18172863 |
| chalcone | increases cleavage | EXP | | 6480464 | Chalcone results in increased cleavage of PARP1 protein | CTD | PMID:20620131 |
| chalcone | multiple interactions | EXP | | 6480464 | MYC protein affects the susceptibility to [Chalcone results in increased cleavage of PARP1 protein] | CTD | PMID:20620131 |
| chenodeoxycholic acid | multiple interactions | EXP | | 6480464 | [Chenodeoxycholic Acid co-treated with tauroursodeoxycholic acid] results in increased cleavage of PARP1 protein | CTD | PMID:14976352 |
| chenodeoxycholic acid | increases cleavage | EXP | | 6480464 | Chenodeoxycholic Acid results in increased cleavage of PARP1 protein | CTD | PMID:14976352 |
| chloramphenicol | multiple interactions | EXP | | 6480464 | CDKN1A mutant form inhibits the reaction [Chloramphenicol inhibits the reaction [Mitomycin results in increased activity of PARP1 protein]] | CTD | PMID:15905168 |
| chlorpyrifos | multiple interactions | ISO | RGD:2053 | 6480464 | Acetylcysteine inhibits the reaction [Chlorpyrifos results in increased cleavage of PARP1 protein] | CTD | PMID:22714038 |
| chlorpyrifos | increases cleavage | ISO | RGD:2053 | 6480464 | Chlorpyrifos results in increased cleavage of PARP1 protein | CTD | PMID:22714038 |
| ciglitazone | multiple interactions | EXP | | 6480464 | benzyloxycarbonyl-isoleucyl-glutamyl-threonyl-aspartic acid fluoromethyl ketone inhibits the reaction [ciglitazone promotes the reaction [Niflumic Acid results in increased cleavage of PARP1 protein]]; more ... | CTD | PMID:21067863 |
| ciglitazone | increases cleavage | EXP | | 6480464 | ciglitazone results in increased cleavage of PARP1 protein | CTD | PMID:21067863 |
| ciglitazone | multiple interactions | EXP | | 6480464 | ciglitazone results in increased cleavage of and results in increased activity of PARP1 protein | CTD | PMID:15492468 |
| ciprofloxacin | increases cleavage | EXP | | 6480464 | Ciprofloxacin results in increased cleavage of PARP1 protein | CTD | PMID:10741713 |
| cisplatin | multiple interactions | EXP | | 6480464 | [3-aminobenzamide results in decreased activity of PARP1 protein] which results in increased susceptibility to Cisplatin | CTD | PMID:21399878 |
| cisplatin | multiple interactions | EXP | | 6480464 | [2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [FAM168A results in decreased susceptibility to Cisplatin]] which results in increased cleavage of PARP1 protein; more ... | CTD | PMID:23251525 |
| cisplatin | increases cleavage | EXP | | 6480464 | Cisplatin results in increased cleavage of PARP1 protein | CTD | PMID:15496615 more ... |
| cisplatin | increases cleavage | EXP | | 6480464 | Cisplatin results in increased cleavage of PARP1 protein | CTD | PMID:15496615 more ... |
| cisplatin | increases cleavage | EXP | | 6480464 | Cisplatin results in increased cleavage of PARP1 protein | CTD | PMID:21618512 more ... |
| cisplatin | increases cleavage | EXP | | 6480464 | Cisplatin results in increased cleavage of PARP1 protein | CTD | PMID:16009487 more ... |
| cisplatin | increases cleavage | EXP | | 6480464 | Cisplatin results in increased cleavage of PARP1 protein | CTD | PMID:16009487 more ... |
| cisplatin | increases cleavage | EXP | | 6480464 | Cisplatin results in increased cleavage of PARP1 protein | CTD | PMID:21266360 more ... |
| cisplatin | decreases response to substance | EXP | | 6480464 | PARP1 protein results in decreased susceptibility to Cisplatin | CTD | PMID:21447800 |
| cisplatin | decreases activity | EXP | | 6480464 | Cisplatin results in decreased activity of PARP1 protein | CTD | PMID:21370912 |
| cisplatin | multiple interactions | EXP | | 6480464 | CITED2 mutant form promotes the reaction [Cisplatin results in increased cleavage of PARP1 protein]; more ... | CTD | PMID:21660965 |
| cisplatin | increases expression | EXP | | 6480464 | Cisplatin results in increased expression of PARP1 protein | CTD | PMID:21274007 |
| cisplatin | increases cleavage | EXP | | 6480464 | Cisplatin results in increased cleavage of PARP1 protein | CTD | PMID:21618512 more ... |
| cisplatin | multiple interactions | EXP | | 6480464 | [Cisplatin results in increased activity of CASP3 protein] which results in increased cleavage of PARP1 protein | CTD | PMID:18176112 |
| cisplatin | multiple interactions | EXP | | 6480464 | Cisplatin inhibits the reaction [Zinc binds to PARP1 protein]; more ... | CTD | PMID:21370912 |
| cisplatin | multiple interactions | EXP | | 6480464 | BCL2 inhibits the reaction [Cisplatin results in increased cleavage of PARP1 protein] | CTD | PMID:21618512 |
| cisplatin | multiple interactions | EXP | | 6480464 | [BIN1 protein results in decreased activity of PARP1 protein] which results in increased susceptibility to Cisplatin | CTD | PMID:21447800 |
| cisplatin | multiple interactions | EXP | | 6480464 | AKT1 protein inhibits the reaction [Cisplatin results in increased cleavage of PARP1 protein] | CTD | PMID:21266360 |
| cisplatin | multiple interactions | EXP | | 6480464 | Acetylcysteine inhibits the reaction [Cisplatin results in increased cleavage of PARP1 protein] | CTD | PMID:15496615 |
| citalopram | increases cleavage | EXP | | 6480464 | Citalopram results in increased cleavage of PARP1 protein | CTD | PMID:10487422 |
| cladribine | multiple interactions | EXP | | 6480464 | [Cladribine co-treated with Cyclophosphamide] results in decreased expression of PARP1 protein; more ... | CTD | PMID:15582267 |
| cladribine | increases cleavage | EXP | | 6480464 | Cladribine results in increased cleavage of PARP1 protein | CTD | PMID:15582267 PMID:21679466 |
| cladribine | increases cleavage | EXP | | 6480464 | Cladribine results in increased cleavage of PARP1 protein | CTD | PMID:21679466 PMID:15582267 |
| clofarabine | multiple interactions | EXP | | 6480464 | [clofarabine co-treated with fludarabine co-treated with Busulfan] results in increased cleavage of PARP1 protein | CTD | PMID:20933509 |
| clofibric acid | multiple interactions | ISO | RGD:2053 | 6480464 | [Diethylnitrosamine co-treated with Clofibric Acid] affects the expression of PARP1 mRNA | CTD | PMID:17602206 |
| clomipramine | increases cleavage | EXP | | 6480464 | Clomipramine results in increased cleavage of PARP1 protein | CTD | PMID:10487422 |
| cobalt dichloride | decreases expression | EXP | | 6480464 | cobaltous chloride results in decreased expression of PARP1 mRNA | CTD | PMID:19320972 |
| cobalt dichloride | multiple interactions | EXP | | 6480464 | cobaltous chloride inhibits the reaction [Doxorubicin promotes the reaction [[PARP1 protein binds to TNFRSF10B promoter] which results in increased expression of TNFRSF10B mRNA]]; more ... | CTD | PMID:19714248 |
| cocaine | affects expression | ISO | RGD:1551988 | 6480464 | Cocaine affects the expression of PARP1 mRNA | CTD | PMID:15681117 |
| cocaine | increases cleavage | ISO | RGD:2053 | 6480464 | Cocaine results in increased cleavage of PARP1 protein | CTD | PMID:17084983 |
| copper atom | multiple interactions | EXP | | 6480464 | [Disulfiram binds to Copper] which results in increased cleavage of PARP1 protein | CTD | PMID:17079463 |
| copper atom | multiple interactions | EXP | | 6480464 | [NSC 689534 binds to Copper] which results in decreased expression of PARP1 mRNA; more ... | CTD | PMID:20971185 |
| copper(0) | multiple interactions | EXP | | 6480464 | [Disulfiram binds to Copper] which results in increased cleavage of PARP1 protein | CTD | PMID:17079463 |
| copper(0) | multiple interactions | EXP | | 6480464 | [NSC 689534 binds to Copper] which results in decreased expression of PARP1 mRNA; more ... | CTD | PMID:20971185 |
| copper(2+) sulfate | decreases expression | EXP | | 6480464 | Copper Sulfate results in decreased expression of PARP1 mRNA | CTD | PMID:19549813 |
| copper(II) chloride | multiple interactions | EXP | | 6480464 | [Disulfiram co-treated with cupric chloride] results in increased cleavage of PARP1 protein | CTD | PMID:19789329 |
| coumarin | decreases activity | EXP | | 6480464 | coumarin results in decreased activity of PARP1 protein | CTD | PMID:17669606 |
| coumarin | multiple interactions | EXP | | 6480464 | [coumarin results in decreased activity of PARP1 protein] inhibits the reaction [Tetrachlorodibenzodioxin results in decreased abundance of NAD]; more ... | CTD | PMID:17669606 |
| coumestrol | multiple interactions | EXP | | 6480464 | [Coumestrol co-treated with resveratrol] results in increased expression of PARP1 mRNA; more ... | CTD | PMID:19167446 |
| curcumin | multiple interactions | EXP | | 6480464 | [Curcumin co-treated with bortezomib] results in increased cleavage of PARP1 protein; more ... | CTD | PMID:19372569 |
| curcumin | multiple interactions | ISO | RGD:1551988 | 6480464 | Curcumin inhibits the reaction [sodium arsenite results in increased cleavage of PARP1 protein] | CTD | PMID:11035063 |
| curcumin | multiple interactions | EXP | | 6480464 | Curcumin promotes the reaction [arsenite results in increased expression of PARP1 protein] | CTD | PMID:18392098 |
| curcumin | increases cleavage | EXP | | 6480464 | Curcumin results in increased cleavage of PARP1 protein | CTD | PMID:14555224 more ... |
| curcumin | increases cleavage | EXP | | 6480464 | Curcumin results in increased cleavage of PARP1 protein | CTD | PMID:19235267 more ... |
| curcumin | increases cleavage | EXP | | 6480464 | Curcumin results in increased cleavage of PARP1 protein | CTD | PMID:17671742 more ... |
| curcumin | increases cleavage | EXP | | 6480464 | Curcumin results in increased cleavage of PARP1 protein | CTD | PMID:17671742 more ... |
| curcumin | increases cleavage | EXP | | 6480464 | Curcumin results in increased cleavage of PARP1 protein | CTD | PMID:14555224 more ... |
| curcumin | increases cleavage | EXP | | 6480464 | Curcumin results in increased cleavage of PARP1 protein | CTD | PMID:14555224 more ... |
| curcumin | multiple interactions | ISO | RGD:2053 | 6480464 | Curcumin inhibits the reaction [tert-Butylhydroperoxide results in increased cleavage of PARP1 protein] | CTD | PMID:15569404 |
| curcumin | multiple interactions | ISO | RGD:1551988 | 6480464 | [Doxorubicin co-treated with Curcumin] results in increased cleavage of PARP1 protein | CTD | PMID:18006147 |
| curcumin | increases cleavage | ISO | RGD:1551988 | 6480464 | Curcumin results in increased cleavage of PARP1 protein | CTD | PMID:21594647 |
| curcumin | increases degradation | EXP | | 6480464 | Curcumin results in increased degradation of PARP1 | CTD | PMID:21595920 |
| curcumin | increases cleavage | EXP | | 6480464 | Curcumin results in increased cleavage of PARP1 protein | CTD | PMID:14555224 more ... |
| curcumin | multiple interactions | EXP | | 6480464 | Curcumin results in increased cleavage of and results in increased activity of PARP1 protein | CTD | PMID:16173963 |
| curcumin | multiple interactions | EXP | | 6480464 | Curcumin inhibits the reaction [docetaxel results in increased cleavage of PARP1 protein] | CTD | PMID:14724571 |
| curcumin | multiple interactions | EXP | | 6480464 | Curcumin inhibits the reaction [Arsenic results in decreased expression of PARP1 mRNA]; more ... | CTD | PMID:21332098 |
| cycloheximide | multiple interactions | EXP | | 6480464 | [Cycloheximide co-treated with TNF protein] results in increased cleavage of PARP1 protein; more ... | CTD | PMID:12925536 |
| cycloheximide | multiple interactions | EXP | | 6480464 | [Cycloheximide co-treated with TNFSF10 protein] results in increased cleavage of PARP1 protein | CTD | PMID:18222423 |
| cycloheximide | multiple interactions | ISO | RGD:2053 | 6480464 | Cycloheximide inhibits the reaction [ammonium acetate results in increased expression of PARP1 protein] | CTD | PMID:15147502 |
| cycloheximide | increases cleavage | EXP | | 6480464 | Cycloheximide results in increased cleavage of PARP1 protein | CTD | PMID:16051428 |
| cyclophosphamide | multiple interactions | EXP | | 6480464 | [Cladribine co-treated with Cyclophosphamide co-treated with Mitoxantrone] results in decreased expression of PARP1 protein; more ... | CTD | PMID:15582267 |
| cyclophosphamide | increases expression | ISO | RGD:2053 | 6480464 | Cyclophosphamide results in increased expression of PARP1 mRNA | CTD | PMID:11599041 |
| cyclophosphamide | increases cleavage | ISO | RGD:2053 | 6480464 | Cyclophosphamide results in increased cleavage of PARP1 protein | CTD | PMID:11723234 |
| cyclophosphamide | increases cleavage | EXP | | 6480464 | Cyclophosphamide results in increased cleavage of PARP1 protein | CTD | PMID:17898787 |
| cyclophosphamide | decreases expression | ISO | RGD:2053 | 6480464 | Cyclophosphamide results in decreased expression of PARP1 mRNA | CTD | PMID:11906922 |
| cyclosporin A | increases cleavage | EXP | | 6480464 | Cyclosporine results in increased cleavage of PARP1 protein | CTD | PMID:22155090 |
| cyclosporin A | increases cleavage | ISO | RGD:1551988 | 6480464 | Cyclosporine results in increased cleavage of PARP1 protein | CTD | PMID:22155090 |
| cyclosporin A | multiple interactions | ISO | RGD:1551988 | 6480464 | 2-dimethylamino-4,5,6,7-tetrabromo-1H-benzimidazole inhibits the reaction [Cyclosporine results in increased cleavage of PARP1 protein]; more ... | CTD | PMID:22155090 |
| cyclosporin A | multiple interactions | EXP | | 6480464 | salubrinal inhibits the reaction [Cyclosporine results in increased cleavage of PARP1 protein] | CTD | PMID:22155090 |
| cypermethrin | multiple interactions | EXP | | 6480464 | cypermethrin inhibits the reaction [Docosahexaenoic Acids results in increased degradation of PARP1 protein] | CTD | PMID:11341974 |
| cytarabine | multiple interactions | EXP | | 6480464 | [Cytarabine co-treated with TNFSF10 protein] results in increased cleavage of PARP1 protein | CTD | PMID:12780785 |
| D-glucose | multiple interactions | ISO | RGD:2053 | 6480464 | [INS1 protein co-treated with Glucose] results in increased activity of PARP1 protein; more ... | CTD | PMID:18545258 |
| D-glucose | decreases expression | ISO | RGD:2053 | 6480464 | Glucose results in decreased expression of PARP1 mRNA | CTD | PMID:21818840 |
| D-glucose | multiple interactions | ISO | RGD:2053 | 6480464 | Simvastatin inhibits the reaction [Glucose results in increased activity of PARP1 protein] | CTD | PMID:18004065 |
| D-glucose | increases activity | ISO | RGD:2053 | 6480464 | Glucose results in increased activity of PARP1 protein | CTD | PMID:18004065 |
| D-glucose | multiple interactions | EXP | | 6480464 | [Glucose deficiency co-treated with Acetylcysteine] results in increased cleavage of PARP1 protein; more ... | CTD | PMID:17309078 |
| daidzein | increases cleavage | EXP | | 6480464 | daidzein results in increased cleavage of PARP1 protein | CTD | PMID:12791511 |
| daunorubicin | multiple interactions | EXP | | 6480464 | [Daunorubicin co-treated with TNFSF10 protein] results in increased cleavage of PARP1 protein | CTD | PMID:12780785 |
| daunorubicin | increases cleavage | EXP | | 6480464 | Daunorubicin results in increased cleavage of PARP1 protein | CTD | PMID:11082532 PMID:10766178 |
| daunorubicin | increases cleavage | EXP | | 6480464 | Daunorubicin results in increased cleavage of PARP1 protein | CTD | PMID:10766178 PMID:11082532 |
| DDE | increases activity | EXP | | 6480464 | Dichlorodiphenyl Dichloroethylene results in increased activity of PARP1 protein | CTD | PMID:19545618 |
| delphinidin | decreases activity | EXP | | 6480464 | delphinidin results in decreased activity of PARP1 protein | CTD | PMID:17884996 |
| Delta(9)-tetrahydrocannabinol | increases cleavage | EXP | | 6480464 | Tetrahydrocannabinol results in increased cleavage of PARP1 protein | CTD | PMID:17583570 PMID:19509271 |
| Delta(9)-tetrahydrocannabinol | decreases expression | EXP | | 6480464 | Tetrahydrocannabinol results in decreased expression of PARP1 protein | CTD | PMID:16818634 |
| deoxycholic acid | increases cleavage | EXP | | 6480464 | Deoxycholic Acid results in increased cleavage of PARP1 protein | CTD | PMID:17644113 |
| deoxycholic acid | increases cleavage | EXP | | 6480464 | Deoxycholic Acid results in increased cleavage of PARP1 protein | CTD | PMID:17644113 PMID:21362092 |
| deoxycholic acid | increases cleavage | EXP | | 6480464 | Deoxycholic Acid results in increased cleavage of PARP1 protein | CTD | PMID:21362092 PMID:17644113 |
| deoxycholic acid | multiple interactions | EXP | | 6480464 | cobaltiprotoporphyrin inhibits the reaction [Deoxycholic Acid results in increased cleavage of PARP1 protein] | CTD | PMID:21362092 |
| deoxycholic acid | multiple interactions | EXP | | 6480464 | Aspirin inhibits the reaction [Deoxycholic Acid results in increased cleavage of PARP1 protein] | CTD | PMID:17644113 |
| dexamethasone | multiple interactions | EXP | | 6480464 | Dexamethasone promotes the reaction [2-(1H-indazol-4-yl)-6-(4-methanesulfonylpiperazin-1-ylmethyl)-4-morpholin-4-ylthieno(3,2-d)pyrimidine results in increased cleavage of PARP1 protein] | CTD | PMID:23318440 |
| dexamethasone | multiple interactions | ISO | RGD:1551988 | 6480464 | Mifepristone inhibits the reaction [Dexamethasone results in increased cleavage of PARP1 protein] | CTD | PMID:16644695 |
| dexamethasone | increases cleavage | ISO | RGD:1551988 | 6480464 | Dexamethasone results in increased cleavage of PARP1 protein | CTD | PMID:16644695 |
| dexamethasone | multiple interactions | EXP | | 6480464 | Dexamethasone inhibits the reaction [TNFSF10 protein results in increased cleavage of PARP1 protein] | CTD | PMID:16144937 |
| dextran sulfate | increases cleavage | ISO | RGD:1551988 | 6480464 | Dextran Sulfate results in increased cleavage of PARP1 protein | CTD | PMID:21989142 |
| dextran sulfate | multiple interactions | ISO | RGD:1551988 | 6480464 | Plant Extracts inhibits the reaction [Dextran Sulfate results in increased cleavage of PARP1 protein] | CTD | PMID:21989142 |
| diarsenic trioxide | increases cleavage | ISO | RGD:1551988 | 6480464 | arsenic trioxide results in increased cleavage of PARP1 protein | CTD | PMID:21565247 PMID:15761769 |
| diarsenic trioxide | increases cleavage | EXP | | 6480464 | arsenic trioxide results in increased cleavage of PARP1 protein | CTD | PMID:10382944 more ... |
| diarsenic trioxide | multiple interactions | EXP | | 6480464 | NCF2 mutant form inhibits the reaction [arsenic trioxide results in increased cleavage of PARP1 protein] | CTD | PMID:22532027 |
| diarsenic trioxide | increases cleavage | EXP | | 6480464 | arsenic trioxide results in increased cleavage of PARP1 protein | CTD | PMID:10382944 more ... |
| diarsenic trioxide | affects localization | EXP | | 6480464 | arsenic trioxide affects the localization of PARP1 protein modified form | CTD | PMID:15131059 |
| diarsenic trioxide | increases cleavage | EXP | | 6480464 | arsenic trioxide results in increased cleavage of PARP1 protein | CTD | PMID:10382944 more ... |
| diarsenic trioxide | increases cleavage | EXP | | 6480464 | arsenic trioxide results in increased cleavage of PARP1 protein | CTD | PMID:12931215 more ... |
| diarsenic trioxide | increases cleavage | EXP | | 6480464 | arsenic trioxide results in increased cleavage of PARP1 protein | CTD | PMID:16646077 more ... |
| diarsenic trioxide | increases cleavage | ISO | RGD:1551988 | 6480464 | arsenic trioxide results in increased cleavage of PARP1 protein | CTD | PMID:15761769 |
| diarsenic trioxide | multiple interactions | ISO | RGD:1551988 | 6480464 | [Genistein co-treated with arsenic trioxide] results in increased cleavage of PARP1 protein | CTD | PMID:21078540 |
| diarsenic trioxide | multiple interactions | EXP | | 6480464 | [arsenic trioxide co-treated with bortezomib] results in increased degradation of PARP1 protein | CTD | PMID:17495969 |
| diarsenic trioxide | multiple interactions | EXP | | 6480464 | [Genistein co-treated with arsenic trioxide] results in increased cleavage of PARP1 protein | CTD | PMID:21078540 |
| diarsenic trioxide | increases cleavage | EXP | | 6480464 | arsenic trioxide results in increased cleavage of PARP1 protein | CTD | PMID:12181429 more ... |
| diarsenic trioxide | multiple interactions | EXP | | 6480464 | arsenic trioxide results in increased cleavage of and results in increased activity of PARP1 protein; more ... | CTD | PMID:19408305 |
| diarsenic trioxide | decreases expression | EXP | | 6480464 | arsenic trioxide results in decreased expression of PARP1 protein | CTD | PMID:19695276 |
| diarsenic trioxide | multiple interactions | EXP | | 6480464 | arsenic trioxide promotes the reaction [zoledronic acid results in increased cleavage of PARP1 protein] | CTD | PMID:20977926 |
| diarsenic trioxide | multiple interactions | EXP | | 6480464 | [arsenic trioxide co-treated with MIR15A co-treated with MIR16-1] results in increased cleavage of PARP1 protein | CTD | PMID:21056550 |
| diarsenic trioxide | multiple interactions | EXP | | 6480464 | anthra(1,9-cd)pyrazol-6(2H)-one inhibits the reaction [arsenic trioxide results in increased cleavage of PARP1 protein]; more ... | CTD | PMID:16328441 |
| diarsenic trioxide | multiple interactions | EXP | | 6480464 | Acetylcysteine inhibits the reaction [[Sulindac co-treated with arsenic trioxide] results in increased cleavage of PARP1 protein]; more ... | CTD | PMID:18281123 |
| diarsenic trioxide | multiple interactions | EXP | | 6480464 | 3,4-dihydro-5-(4-(1-piperidinyl)butoxy)-1(2H)-isoquinolinone inhibits the reaction [[arsenic trioxide co-treated with phytosphingosine] results in increased activity of PARP1 protein]; more ... | CTD | PMID:17237268 |
| diarsenic trioxide | increases cleavage | EXP | | 6480464 | arsenic trioxide results in increased cleavage of PARP1 protein | CTD | PMID:19364129 more ... |
| diarsenic trioxide | increases cleavage | EXP | | 6480464 | arsenic trioxide results in increased cleavage of PARP1 protein | CTD | PMID:20435036 more ... |
| diarsenic trioxide | increases cleavage | EXP | | 6480464 | arsenic trioxide results in increased cleavage of PARP1 protein | CTD | PMID:16328441 more ... |
| diarsenic trioxide | multiple interactions | ISO | RGD:1551988 | 6480464 | Acetylcysteine inhibits the reaction [arsenic trioxide results in increased cleavage of PARP1 protein] | CTD | PMID:21565247 |
| diarsenic trioxide | increases cleavage | ISO | RGD:1551988 | 6480464 | arsenic trioxide results in increased cleavage of PARP1 protein | CTD | PMID:15761769 PMID:21565247 |
| diarsenic trioxide | multiple interactions | EXP | | 6480464 | 17-(dimethylaminoethylamino)-17-demethoxygeldanamycin promotes the reaction [arsenic trioxide results in increased cleavage of PARP1 protein]; more ... | CTD | PMID:19371599 |
| dibutyl phthalate | increases expression | ISO | RGD:1551988 | 6480464 | Dibutyl Phthalate results in increased expression of PARP1 mRNA | CTD | PMID:21266533 |
| dibutyl phthalate | decreases expression | ISO | RGD:1551988 | 6480464 | Dibutyl Phthalate results in decreased expression of PARP1 mRNA | CTD | PMID:21266533 |
| dieldrin | increases cleavage | ISO | RGD:2053 | 6480464 | Dieldrin results in increased cleavage of PARP1 protein | CTD | PMID:15183012 |
| dieldrin | multiple interactions | ISO | RGD:2053 | 6480464 | benzoylcarbonyl-aspartyl-glutamyl-valyl-aspartyl-fluoromethyl ketone inhibits the reaction [Dieldrin results in increased cleavage of PARP1 protein] | CTD | PMID:15183012 |
| diepoxybutane | increases cleavage | EXP | | 6480464 | erythritol anhydride results in increased cleavage of PARP1 protein | CTD | PMID:14998682 |
| diethyl maleate | increases cleavage | EXP | | 6480464 | diethyl maleate results in increased cleavage of PARP1 protein | CTD | PMID:21105742 |
| dimethyl maleate | increases cleavage | EXP | | 6480464 | dimethyl maleate results in increased cleavage of PARP1 protein | CTD | PMID:21105742 |
| dimethyl sulfoxide | increases cleavage | ISO | RGD:1551988 | 6480464 | Dimethyl Sulfoxide results in increased cleavage of PARP1 protein | CTD | PMID:22535522 |
| dioxygen | increases cleavage | ISO | RGD:2053 | 6480464 | Oxygen deficiency results in increased cleavage of PARP1 protein | CTD | PMID:11042672 |
| dioxygen | increases cleavage | EXP | | 6480464 | Oxygen deficiency results in increased cleavage of PARP1 protein | CTD | PMID:20530905 |
| dioxygen | multiple interactions | EXP | | 6480464 | N-ethoxymethyl-3-amino-1,2,4-benzotriazine-1,4-dioxide promotes the reaction [Oxygen deficiency results in increased cleavage of PARP1 protein] | CTD | PMID:20530905 |
| dioxygen | multiple interactions | ISO | RGD:2053 | 6480464 | Phenylephrine inhibits the reaction [Oxygen deficiency results in increased cleavage of PARP1 protein] | CTD | PMID:11042672 |
| disodium selenite | increases cleavage | EXP | | 6480464 | Sodium Selenite results in increased cleavage of PARP1 protein | CTD | PMID:15845651 |
| disodium selenite | decreases activity | ISO | RGD:2053 | 6480464 | Sodium Selenite results in decreased activity of PARP1 protein | CTD | PMID:18209489 |
| disodium selenite | increases expression | EXP | | 6480464 | Sodium Selenite results in increased expression of PARP1 mRNA | CTD | PMID:18175754 |
| disulfiram | multiple interactions | EXP | | 6480464 | [Disulfiram binds to Copper] which results in increased cleavage of PARP1 protein | CTD | PMID:17079463 |
| disulfiram | increases cleavage | EXP | | 6480464 | Disulfiram results in increased cleavage of PARP1 protein | CTD | PMID:17079463 |
| disulfiram | multiple interactions | EXP | | 6480464 | [Disulfiram co-treated with cupric chloride] results in increased cleavage of PARP1 protein | CTD | PMID:19789329 |
| docetaxel anhydrous | multiple interactions | EXP | | 6480464 | anthra(1,9-cd)pyrazol-6(2H)-one inhibits the reaction [docetaxel results in increased cleavage of PARP1 protein]; more ... | CTD | PMID:14724571 |
| docetaxel anhydrous | increases cleavage | EXP | | 6480464 | docetaxel results in increased cleavage of PARP1 protein | CTD | PMID:14724571 more ... |
| docetaxel anhydrous | increases cleavage | EXP | | 6480464 | docetaxel results in increased cleavage of PARP1 protein | CTD | PMID:17308071 more ... |
| docetaxel anhydrous | increases cleavage | EXP | | 6480464 | docetaxel results in increased cleavage of PARP1 protein | CTD | PMID:18186959 more ... |
| docetaxel anhydrous | increases cleavage | EXP | | 6480464 | docetaxel results in increased cleavage of PARP1 protein | CTD | PMID:19715609 more ... |
| docetaxel anhydrous | increases cleavage | EXP | | 6480464 | docetaxel results in increased cleavage of PARP1 protein | CTD | PMID:19715609 more ... |
| docetaxel anhydrous | increases cleavage | EXP | | 6480464 | docetaxel results in increased cleavage of PARP1 protein | CTD | PMID:18186959 more ... |
| docetaxel anhydrous | increases cleavage | EXP | | 6480464 | docetaxel results in increased cleavage of PARP1 protein | CTD | PMID:14724571 more ... |
| docetaxel anhydrous | multiple interactions | EXP | | 6480464 | docetaxel promotes the reaction [TNFSF10 results in increased cleavage of PARP1 protein] | CTD | PMID:18404675 |
| docetaxel anhydrous | multiple interactions | EXP | | 6480464 | celecoxib promotes the reaction [docetaxel results in increased cleavage of and results in increased expression of PARP1 protein]; more ... | CTD | PMID:15688368 |
| docetaxel anhydrous | multiple interactions | EXP | | 6480464 | benzoylcarbonyl-valyl-aspartyl-valyl-alanyl-aspartyl-fluoromethyl ketone inhibits the reaction [docetaxel results in increased cleavage of PARP1 protein] | CTD | PMID:17308071 |
| dopamine | increases cleavage | EXP | | 6480464 | Dopamine results in increased cleavage of PARP1 protein | CTD | PMID:17603292 PMID:15198987 |
| dopamine | increases cleavage | EXP | | 6480464 | Dopamine results in increased cleavage of PARP1 protein | CTD | PMID:15198987 more ... |
| dopamine | increases cleavage | EXP | | 6480464 | Dopamine results in increased cleavage of PARP1 protein | CTD | PMID:15198987 PMID:17603292 |
| dopamine | multiple interactions | EXP | | 6480464 | resveratrol inhibits the reaction [Dopamine results in increased cleavage of PARP1 protein] | CTD | PMID:17603292 |
| dopamine | multiple interactions | EXP | | 6480464 | PARK2 protein inhibits the reaction [Dopamine results in increased cleavage of PARP1 protein] | CTD | PMID:15198987 |
| doxorubicin | multiple interactions | EXP | | 6480464 | 4-amino-1,8-naphthalimide inhibits the reaction [Doxorubicin results in increased activity of PARP1 protein] | CTD | PMID:15456408 |
| doxorubicin | multiple interactions | EXP | | 6480464 | 2-(1H-indazol-4-yl)-6-(4-methanesulfonylpiperazin-1-ylmethyl)-4-morpholin-4-ylthieno(3,2-d)pyrimidine promotes the reaction [Doxorubicin results in increased cleavage of PARP1 protein]; more ... | CTD | PMID:20826841 |
| doxorubicin | increases cleavage | EXP | | 6480464 | Doxorubicin results in increased cleavage of PARP1 protein | CTD | PMID:10766178 more ... |
| doxorubicin | increases cleavage | ISO | RGD:1551988 | 6480464 | Doxorubicin results in increased cleavage of PARP1 protein | CTD | PMID:10704466 PMID:20363884 |
| doxorubicin | increases cleavage | ISO | RGD:2053 | 6480464 | Doxorubicin results in increased cleavage of PARP1 protein | CTD | PMID:16687611 more ... |
| doxorubicin | decreases cleavage | ISO | RGD:2053 | 6480464 | Doxorubicin results in decreased cleavage of PARP1 protein | CTD | PMID:22155320 |
| doxorubicin | increases expression | ISO | RGD:1551988 | 6480464 | Doxorubicin results in increased expression of PARP1 protein | CTD | PMID:20144634 |
| doxorubicin | multiple interactions | ISO | RGD:2053 | 6480464 | kaempferol inhibits the reaction [Doxorubicin results in increased cleavage of PARP1 protein] | CTD | PMID:22155320 |
| doxorubicin | increases expression | ISO | RGD:2053 | 6480464 | Doxorubicin results in increased expression of PARP1 protein | CTD | PMID:12967636 PMID:21194538 |
| doxorubicin | multiple interactions | ISO | RGD:2053 | 6480464 | Doxorubicin results in increased expression of and results in increased cleavage of PARP1 protein | CTD | PMID:21194538 |
| doxorubicin | increases cleavage | EXP | | 6480464 | Doxorubicin results in increased cleavage of PARP1 protein | CTD | PMID:10766178 more ... |
| doxorubicin | multiple interactions | ISO | RGD:1551988 | 6480464 | Silymarin inhibits the reaction [Doxorubicin results in increased expression of PARP1 protein] | CTD | PMID:20144634 |
| doxorubicin | increases cleavage | EXP | | 6480464 | Doxorubicin results in increased cleavage of PARP1 protein | CTD | PMID:18281512 more ... |
| doxorubicin | multiple interactions | EXP | | 6480464 | cobaltous chloride inhibits the reaction [Doxorubicin promotes the reaction [[PARP1 protein binds to TNFRSF10B promoter] which results in increased expression of TNFRSF10B mRNA]]; more ... | CTD | PMID:19714248 |
| doxorubicin | increases cleavage | ISO | RGD:2053 | 6480464 | Doxorubicin results in increased cleavage of PARP1 protein | CTD | PMID:17285121 more ... |
| doxorubicin | increases cleavage | ISO | RGD:2053 | 6480464 | Doxorubicin results in increased cleavage of PARP1 protein | CTD | PMID:16687611 more ... |
| doxorubicin | increases cleavage | EXP | | 6480464 | Doxorubicin results in increased cleavage of PARP1 protein | CTD | PMID:15555623 more ... |
| doxorubicin | increases cleavage | ISO | RGD:2053 | 6480464 | Doxorubicin results in increased cleavage of PARP1 protein | CTD | PMID:16687611 more ... |
| doxorubicin | increases cleavage | EXP | | 6480464 | Doxorubicin results in increased cleavage of PARP1 protein | CTD | PMID:16890185 more ... |
| doxorubicin | increases cleavage | ISO | RGD:2053 | 6480464 | Doxorubicin results in increased cleavage of PARP1 protein | CTD | PMID:18775851 more ... |
| doxorubicin | increases cleavage | EXP | | 6480464 | Doxorubicin results in increased cleavage of PARP1 protein | CTD | PMID:18281512 more ... |
| doxorubicin | increases cleavage | ISO | RGD:2053 | 6480464 | Doxorubicin results in increased cleavage of PARP1 protein | CTD | PMID:17285121 more ... |
| doxorubicin | increases cleavage | EXP | | 6480464 | Doxorubicin results in increased cleavage of PARP1 protein | CTD | PMID:17651020 more ... |
| doxorubicin | multiple interactions | ISO | RGD:2053 | 6480464 | TNF protein promotes the reaction [Doxorubicin results in increased cleavage of PARP1 protein] | CTD | PMID:17651020 |
| doxorubicin | multiple interactions | ISO | RGD:2053 | 6480464 | PD 98059 inhibits the reaction [Doxorubicin results in increased cleavage of PARP1 protein]; more ... | CTD | PMID:18775851 |
| doxorubicin | multiple interactions | ISO | RGD:2053 | 6480464 | pifithrin inhibits the reaction [Doxorubicin results in increased cleavage of PARP1 protein] | CTD | PMID:16687611 |
| doxorubicin | multiple interactions | ISO | RGD:2053 | 6480464 | HSPE1 protein inhibits the reaction [Doxorubicin results in increased expression of PARP1 protein]; more ... | CTD | PMID:12967636 |
| doxorubicin | increases expression | ISO | RGD:2053 | 6480464 | Doxorubicin results in increased expression of PARP1 protein | CTD | PMID:12967636 |
| doxorubicin | increases cleavage | ISO | RGD:2053 | 6480464 | Doxorubicin results in increased cleavage of PARP1 protein | CTD | PMID:17651020 more ... |
| doxorubicin | multiple interactions | ISO | RGD:2053 | 6480464 | 7-monohydroxyethylrutoside inhibits the reaction [Doxorubicin results in increased cleavage of PARP1 protein] | CTD | PMID:17285121 |
| doxorubicin | increases uptake | ISO | RGD:1551988 | 6480464 | PARP1 protein results in increased uptake of Doxorubicin | CTD | PMID:15861398 |
| doxorubicin | affects response to substance | ISO | RGD:1551988 | 6480464 | PARP1 protein affects the susceptibility to Doxorubicin | CTD | PMID:11861791 |
| doxorubicin | multiple interactions | ISO | RGD:1551988 | 6480464 | PARP1 protein promotes the reaction [Doxorubicin results in increased expression of BECN1 mRNA]; more ... | CTD | PMID:19001878 |
| doxorubicin | multiple interactions | ISO | RGD:1551988 | 6480464 | PARP1 gene mutant form inhibits the reaction [Doxorubicin results in increased phosphorylation of CDK2 protein]; more ... | CTD | PMID:15861398 |
| doxorubicin | increases cleavage | ISO | RGD:1551988 | 6480464 | Doxorubicin results in increased cleavage of PARP1 protein | CTD | PMID:20363884 |
| doxorubicin | multiple interactions | ISO | RGD:1551988 | 6480464 | Doxorubicin promotes the reaction [AZD 6244 results in increased cleavage of PARP1 protein] | CTD | PMID:17876044 |
| doxorubicin | increases activity | ISO | RGD:1551988 | 6480464 | Doxorubicin results in increased activity of PARP1 protein | CTD | PMID:19286953 |
| doxorubicin | multiple interactions | ISO | RGD:1551988 | 6480464 | [Doxorubicin co-treated with Curcumin] results in increased cleavage of PARP1 protein | CTD | PMID:18006147 |
| doxorubicin | multiple interactions | ISO | RGD:1551988 | 6480464 | 5,10,15,20-tetrakis(N-methyl-4'-pyridyl)porphyrinato-iron(III) inhibits the reaction [Doxorubicin results in increased activity of PARP1 protein]; more ... | CTD | PMID:19286953 |
| doxorubicin | multiple interactions | EXP | | 6480464 | wortmannin promotes the reaction [Doxorubicin results in increased cleavage of PARP1 protein] | CTD | PMID:17935137 |
| doxorubicin | multiple interactions | EXP | | 6480464 | U 0126 promotes the reaction [Doxorubicin results in increased cleavage of PARP1 protein] | CTD | PMID:15557793 |
| doxorubicin | multiple interactions | EXP | | 6480464 | TGFB1 protein promotes the reaction [Doxorubicin results in increased degradation of PARP1 protein] | CTD | PMID:17418594 |
| doxorubicin | multiple interactions | EXP | | 6480464 | THBS1 protein inhibits the reaction [Doxorubicin results in increased cleavage of PARP1 protein] | CTD | PMID:16962673 |
| doxorubicin | multiple interactions | EXP | | 6480464 | SB 203580 inhibits the reaction [Doxorubicin results in increased cleavage of PARP1 protein] | CTD | PMID:16843435 |
| doxorubicin | multiple interactions | EXP | | 6480464 | RBL2 protein inhibits the reaction [Doxorubicin results in increased cleavage of PARP1 protein] | CTD | PMID:15585644 |
| doxorubicin | multiple interactions | EXP | | 6480464 | IFNA1 protein promotes the reaction [Doxorubicin results in increased cleavage of PARP1 protein] | CTD | PMID:17959036 |
| doxorubicin | multiple interactions | EXP | | 6480464 | GSTA1 protein inhibits the reaction [Doxorubicin results in increased cleavage of PARP1 protein] | CTD | PMID:16890185 |
| doxorubicin | multiple interactions | EXP | | 6480464 | geldanamycin inhibits the reaction [Doxorubicin results in increased cleavage of PARP1 protein] | CTD | PMID:16311509 |
| doxorubicin | multiple interactions | EXP | | 6480464 | FASN protein inhibits the reaction [Doxorubicin results in increased cleavage of PARP1 protein] | CTD | PMID:18281512 |
| doxorubicin | multiple interactions | EXP | | 6480464 | DPP4 protein promotes the reaction [Doxorubicin results in increased cleavage of PARP1 protein] | CTD | PMID:15753397 |
| doxorubicin | increases degradation | EXP | | 6480464 | Doxorubicin results in increased degradation of PARP1 protein | CTD | PMID:17418594 |
| doxorubicin | increases cleavage | EXP | | 6480464 | Doxorubicin results in increased cleavage of PARP1 protein | CTD | PMID:18281512 more ... |
| doxorubicin | increases activity | EXP | | 6480464 | Doxorubicin results in increased activity of PARP1 protein | CTD | PMID:15456408 |
| doxorubicin | increases cleavage | EXP | | 6480464 | Doxorubicin analog results in increased cleavage of PARP1 protein | CTD | PMID:15981920 |
| doxorubicin | affects cleavage | EXP | | 6480464 | Doxorubicin affects the cleavage of PARP1 protein | CTD | PMID:15870702 |
| doxorubicin | multiple interactions | EXP | | 6480464 | AKT1 protein modified form inhibits the reaction [[Doxorubicin co-treated with methylselenic acid] results in increased degradation of PARP1 protein]; more ... | CTD | PMID:17339365 |
| doxorubicin | multiple interactions | EXP | | 6480464 | 7-monohydroxyethylrutoside inhibits the reaction [Doxorubicin results in increased cleavage of PARP1 protein] | CTD | PMID:17285121 |
| elemental selenium | multiple interactions | EXP | | 6480464 | AKT1 protein modified form inhibits the reaction [[Doxorubicin co-treated with Selenium] results in increased degradation of PARP1 protein]; more ... | CTD | PMID:17339365 |
| emetine | increases cleavage | EXP | | 6480464 | Emetine results in increased cleavage of PARP1 protein | CTD | PMID:21256112 |
| ethanol | increases cleavage | EXP | | 6480464 | Ethanol results in increased cleavage of PARP1 protein | CTD | PMID:21410490 |
| ethanol | increases cleavage | ISO | RGD:1551988 | 6480464 | Ethanol results in increased cleavage of PARP1 protein | CTD | PMID:22535522 |
| ethanol | increases expression | ISO | RGD:2053 | 6480464 | Ethanol results in increased expression of PARP1 mRNA | CTD | PMID:15353170 |
| ethanol | multiple interactions | EXP | | 6480464 | Sirolimus inhibits the reaction [Ethanol results in increased cleavage of PARP1 protein] | CTD | PMID:21410490 |
| ethylene glycol bis(2-aminoethyl)tetraacetic acid | multiple interactions | EXP | | 6480464 | Egtazic Acid inhibits the reaction [Cadmium Chloride results in increased cleavage of PARP1 protein] | CTD | PMID:21544200 |
| ethylene glycol bis(2-aminoethyl)tetraacetic acid | multiple interactions | ISO | RGD:2053 | 6480464 | Egtazic Acid inhibits the reaction [Cadmium Chloride results in increased cleavage of PARP1 protein] | CTD | PMID:21544200 |
| etoposide | increases cleavage | EXP | | 6480464 | Etoposide results in increased cleavage of PARP1 protein | CTD | PMID:12690110 more ... |
| etoposide | increases cleavage | EXP | | 6480464 | Etoposide results in increased cleavage of PARP1 protein | CTD | PMID:16844113 more ... |
| etoposide | increases cleavage | EXP | | 6480464 | Etoposide results in increased cleavage of PARP1 protein | CTD | PMID:16844113 more ... |
| etoposide | increases cleavage | EXP | | 6480464 | Etoposide results in increased cleavage of PARP1 protein | CTD | PMID:20457658 more ... |
| etoposide | increases cleavage | EXP | | 6480464 | Etoposide results in increased cleavage of PARP1 protein | CTD | PMID:21801448 more ... |
| etoposide | increases cleavage | EXP | | 6480464 | Etoposide results in increased cleavage of PARP1 protein | CTD | PMID:17935137 more ... |
| etoposide | multiple interactions | ISO | RGD:2053 | 6480464 | Niacin deficiency affects the reaction [Etoposide results in increased cleavage of PARP1 protein] | CTD | PMID:17516866 |
| etoposide | increases cleavage | ISO | RGD:2053 | 6480464 | Etoposide results in increased cleavage of PARP1 protein | CTD | PMID:17516866 |
| etoposide | multiple interactions | EXP | | 6480464 | Nicotine inhibits the reaction [Etoposide results in increased cleavage of PARP1 protein] | CTD | PMID:20457658 |
| etoposide | multiple interactions | EXP | | 6480464 | wortmannin promotes the reaction [Etoposide results in increased cleavage of PARP1 protein] | CTD | PMID:17935137 |
| etoposide | multiple interactions | EXP | | 6480464 | HTATIP2 protein promotes the reaction [Etoposide results in increased activity of PARP1 protein] | CTD | PMID:16799960 |
| etoposide | multiple interactions | EXP | | 6480464 | [CASP8 co-treated with TP53] affects the reaction [Etoposide results in increased cleavage of PARP1 protein] | CTD | PMID:21801448 |
| etoposide | increases cleavage | EXP | | 6480464 | Etoposide results in increased cleavage of PARP1 protein | CTD | PMID:17935137 more ... |
| eugenol | multiple interactions | ISO | RGD:1551988 | 6480464 | Eugenol affects the reaction [Methylnitronitrosoguanidine affects the cleavage of PARP1 protein] | CTD | PMID:20434464 |
| fisetin | decreases activity | EXP | | 6480464 | fisetin results in decreased activity of PARP1 protein | CTD | PMID:17884996 |
| flavanone | increases cleavage | EXP | | 6480464 | flavanone results in increased cleavage of PARP1 protein | CTD | PMID:22056764 |
| fluoranthene | increases cleavage | EXP | | 6480464 | fluoranthene results in increased cleavage of PARP1 protein | CTD | PMID:21132278 |
| folic acid | increases cleavage | EXP | | 6480464 | Folic Acid results in increased cleavage of PARP1 protein | CTD | PMID:16728583 |
| formaldehyde | decreases expression | ISO | RGD:2053 | 6480464 | Formaldehyde results in decreased expression of PARP1 mRNA | CTD | PMID:17285311 |
| gefitinib | multiple interactions | EXP | | 6480464 | gefitinib affects the reaction [oxaliplatin results in increased cleavage of PARP1 protein] | CTD | PMID:16243822 |
| geldanamycin | multiple interactions | EXP | | 6480464 | geldanamycin inhibits the reaction [Doxorubicin results in increased cleavage of PARP1 protein] | CTD | PMID:16311509 |
| geldanamycin | increases degradation | EXP | | 6480464 | geldanamycin results in increased degradation of PARP1 protein | CTD | PMID:17293044 |
| geldanamycin | multiple interactions | EXP | | 6480464 | Tretinoin inhibits the reaction [geldanamycin results in increased degradation of PARP1 protein] | CTD | PMID:17293044 |
| genistein | multiple interactions | EXP | | 6480464 | [Fluorouracil co-treated with Genistein] results in increased cleavage of PARP1 protein | CTD | PMID:15896711 |
| genistein | increases cleavage | EXP | | 6480464 | Genistein results in increased cleavage of PARP1 protein | CTD | PMID:21078540 PMID:12791511 |
| genistein | increases cleavage | ISO | RGD:1551988 | 6480464 | Genistein results in increased cleavage of PARP1 protein | CTD | PMID:21078540 |
| genistein | increases cleavage | EXP | | 6480464 | Genistein results in increased cleavage of PARP1 protein | CTD | PMID:12791511 PMID:21078540 |
| genistein | multiple interactions | ISO | RGD:1551988 | 6480464 | [Genistein co-treated with arsenic trioxide] results in increased cleavage of PARP1 protein | CTD | PMID:21078540 |
| genistein | multiple interactions | EXP | | 6480464 | [Genistein co-treated with arsenic trioxide] results in increased cleavage of PARP1 protein | CTD | PMID:21078540 |
| glucose | multiple interactions | ISO | RGD:2053 | 6480464 | [INS1 protein co-treated with Glucose] results in increased activity of PARP1 protein; more ... | CTD | PMID:18545258 |
| glucose | decreases expression | ISO | RGD:2053 | 6480464 | Glucose results in decreased expression of PARP1 mRNA | CTD | PMID:21818840 |
| glucose | multiple interactions | ISO | RGD:2053 | 6480464 | Simvastatin inhibits the reaction [Glucose results in increased activity of PARP1 protein] | CTD | PMID:18004065 |
| glucose | increases activity | ISO | RGD:2053 | 6480464 | Glucose results in increased activity of PARP1 protein | CTD | PMID:18004065 |
| glucose | multiple interactions | EXP | | 6480464 | [Glucose deficiency co-treated with Acetylcysteine] results in increased cleavage of PARP1 protein; more ... | CTD | PMID:17309078 |
| glutathione | multiple interactions | EXP | | 6480464 | Glutathione deficiency promotes the reaction [antimony trioxide results in increased cleavage of PARP1 protein] | CTD | PMID:16112521 |
| glutathione | multiple interactions | EXP | | 6480464 | Glutathione inhibits the reaction [2'-benzoyloxycinnamaldehyde results in increased cleavage of PARP1 protein] | CTD | PMID:14660655 |
| gold atom | multiple interactions | EXP | | 6480464 | Organogold Compounds promotes the reaction [Gold binds to PARP1 protein] | CTD | PMID:21370912 |
| gold(0) | multiple interactions | EXP | | 6480464 | Organogold Compounds promotes the reaction [Gold binds to PARP1 protein] | CTD | PMID:21370912 |
| gossypetin | decreases activity | EXP | | 6480464 | gossypetin results in decreased activity of PARP1 protein | CTD | PMID:17884996 |
| herbimycin | increases cleavage | ISO | RGD:1551988 | 6480464 | herbimycin results in increased cleavage of PARP1 protein | CTD | PMID:11035063 |
| hydralazine | multiple interactions | EXP | | 6480464 | [Hydralazine co-treated with Valproic Acid] results in increased expression of PARP1 mRNA | CTD | PMID:17183730 |
| hydrogen peroxide | multiple interactions | EXP | | 6480464 | [BIN1 protein binds to PARP1 protein] inhibits the reaction [Hydrogen Peroxide results in increased activity of PARP1 protein] | CTD | PMID:21447800 |
| hydrogen peroxide | multiple interactions | EXP | | 6480464 | PARP1 mutant form promotes the reaction [Hydrogen Peroxide results in increased abundance of 8-hydroxy-2'-deoxyguanosine] | CTD | PMID:18707137 |
| hydrogen peroxide | increases response to substance | ISO | RGD:1551988 | 6480464 | PARP1 protein results in increased susceptibility to Hydrogen Peroxide | CTD | PMID:20878536 |
| hydrogen peroxide | multiple interactions | ISO | RGD:1551988 | 6480464 | PARP1 protein promotes the reaction [Hydrogen Peroxide results in increased cleavage of CASP9 protein]; more ... | CTD | PMID:20878536 |
| hydrogen peroxide | increases cleavage | ISO | RGD:1551988 | 6480464 | Hydrogen Peroxide results in increased cleavage of PARP1 protein | CTD | PMID:15876423 more ... |
| hydrogen peroxide | increases activity | EXP | | 6480464 | Hydrogen Peroxide results in increased activity of PARP1 protein | CTD | PMID:20953586 more ... |
| hydrogen peroxide | increases activity | EXP | | 6480464 | Hydrogen Peroxide results in increased activity of PARP1 protein | CTD | PMID:20953586 PMID:21447800 |
| hydrogen peroxide | increases expression | EXP | | 6480464 | Hydrogen Peroxide results in increased expression of PARP1 protein modified form | CTD | PMID:16709600 |
| hydrogen peroxide | increases cleavage | ISO | RGD:2053 | 6480464 | Hydrogen Peroxide results in increased cleavage of PARP1 protein | CTD | PMID:22081883 |
| hydrogen peroxide | increases expression | ISO | RGD:2053 | 6480464 | Hydrogen Peroxide results in increased expression of PARP1 protein modified form | CTD | PMID:22081883 |
| hydrogen peroxide | multiple interactions | ISO | RGD:2053 | 6480464 | calycopterin results in decreased susceptibility to [Hydrogen Peroxide results in increased cleavage of PARP1 protein]; more ... | CTD | PMID:22081883 |
| hydrogen peroxide | increases cleavage | ISO | RGD:1551988 | 6480464 | Hydrogen Peroxide results in increased cleavage of PARP1 protein | CTD | PMID:19557877 PMID:15876423 |
| hydrogen peroxide | increases degradation | ISO | RGD:2053 | 6480464 | Hydrogen Peroxide results in increased degradation of PARP1 protein | CTD | PMID:16157298 |
| hydrogen peroxide | multiple interactions | ISO | RGD:1551988 | 6480464 | Quercetin inhibits the reaction [Hydrogen Peroxide results in increased cleavage of PARP1 protein] | CTD | PMID:15876423 |
| hydrogen peroxide | decreases response to substance | ISO | RGD:1551988 | 6480464 | PARP1 gene mutant form results in decreased susceptibility to Hydrogen Peroxide | CTD | PMID:17438151 |
| hydrogen peroxide | increases cleavage | ISO | RGD:1551988 | 6480464 | Hydrogen Peroxide results in increased cleavage of PARP1 protein | CTD | PMID:15876423 PMID:19557877 |
| hydrogen peroxide | increases activity | ISO | RGD:1551988 | 6480464 | Hydrogen Peroxide results in increased activity of PARP1 protein | CTD | PMID:11593040 |
| hydrogen peroxide | multiple interactions | ISO | RGD:1551988 | 6480464 | erigeroflavanone inhibits the reaction [Hydrogen Peroxide results in increased cleavage of PARP1 protein] | CTD | PMID:19557877 |
| hydrogen peroxide | multiple interactions | ISO | RGD:1551988 | 6480464 | benzamide inhibits the reaction [[Hydrogen Peroxide results in increased activity of PARP1 protein] which results in decreased abundance of NAD]; more ... | CTD | PMID:11593040 |
| hydrogen peroxide | multiple interactions | EXP | | 6480464 | TH protein inhibits the reaction [Hydrogen Peroxide results in increased cleavage of PARP1 protein] | CTD | PMID:19815691 |
| hydrogen peroxide | multiple interactions | EXP | | 6480464 | [sodium arsenite co-treated with Hydrogen Peroxide] results in increased cleavage of PARP1 protein | CTD | PMID:18977016 |
| hydrogen peroxide | affects response to substance | EXP | | 6480464 | PARP1 protein affects the susceptibility to Hydrogen Peroxide | CTD | PMID:19111594 |
| hydrogen peroxide | increases cleavage | EXP | | 6480464 | Hydrogen Peroxide results in increased cleavage of PARP1 protein | CTD | PMID:19815691 |
| hydrogen peroxide | multiple interactions | EXP | | 6480464 | dimethylarsinous acid inhibits the reaction [Hydrogen Peroxide results in increased activity of PARP1 protein]; more ... | CTD | PMID:17011244 |
| hydrogen peroxide | increases activity | EXP | | 6480464 | Hydrogen Peroxide results in increased activity of PARP1 protein | CTD | PMID:21447800 |
| hydroquinone | increases cleavage | EXP | | 6480464 | hydroquinone results in increased cleavage of PARP1 protein | CTD | PMID:19064679 |
| hydroquinone | multiple interactions | EXP | | 6480464 | WRN protein inhibits the reaction [hydroquinone results in increased cleavage of PARP1 protein] | CTD | PMID:19064679 |
| imipramine | increases cleavage | EXP | | 6480464 | Imipramine results in increased cleavage of PARP1 protein | CTD | PMID:10487422 |
| indole-3-methanol | multiple interactions | EXP | | 6480464 | indole-3-carbinol promotes the reaction [TNF protein results in increased cleavage of PARP1 protein] | CTD | PMID:15811958 |
| indomethacin | increases cleavage | EXP | | 6480464 | Indomethacin results in increased cleavage of PARP1 protein | CTD | PMID:15804060 more ... |
| indomethacin | increases cleavage | EXP | | 6480464 | Indomethacin results in increased cleavage of PARP1 protein | CTD | PMID:11532860 more ... |
| indomethacin | multiple interactions | EXP | | 6480464 | GW0742 promotes the reaction [Indomethacin results in increased cleavage of PARP1 protein]; more ... | CTD | PMID:21400612 |
| indomethacin | increases cleavage | EXP | | 6480464 | Indomethacin results in increased cleavage of PARP1 protein | CTD | PMID:11532860 more ... |
| indomethacin | increases cleavage | EXP | | 6480464 | Indomethacin results in increased cleavage of PARP1 protein | CTD | PMID:15804060 more ... |
| indomethacin | increases cleavage | EXP | | 6480464 | Indomethacin results in increased cleavage of PARP1 protein | CTD | PMID:15812552 more ... |
| indomethacin | increases cleavage | EXP | | 6480464 | Indomethacin results in increased cleavage of PARP1 protein | CTD | PMID:12663503 more ... |
| indomethacin | increases cleavage | EXP | | 6480464 | Indomethacin results in increased cleavage of PARP1 protein | CTD | PMID:11532860 more ... |
| indomethacin | increases cleavage | EXP | | 6480464 | Indomethacin results in increased cleavage of PARP1 protein | CTD | PMID:12663503 more ... |
| indomethacin | multiple interactions | EXP | | 6480464 | Indomethacin inhibits the reaction [Tetradecanoylphorbol Acetate results in increased activity of PARP1 protein] | CTD | PMID:2126186 |
| indomethacin | multiple interactions | EXP | | 6480464 | Indomethacin promotes the reaction [LTA protein results in increased cleavage of PARP1 protein] | CTD | PMID:17873517 |
| kaempferol | multiple interactions | ISO | RGD:2053 | 6480464 | kaempferol inhibits the reaction [Doxorubicin results in increased cleavage of PARP1 protein] | CTD | PMID:22155320 |
| L-ascorbic acid | multiple interactions | EXP | | 6480464 | Ascorbic Acid inhibits the reaction [Fenretinide results in increased cleavage of PARP1 protein] | CTD | PMID:16407847 |
| L-ascorbic acid | multiple interactions | ISO | RGD:2053 | 6480464 | Ascorbic Acid inhibits the reaction [Potassium Dichromate results in increased cleavage of PARP1 protein] | CTD | PMID:21262251 |
| L-ascorbic acid | multiple interactions | ISO | RGD:2053 | 6480464 | Ascorbic Acid inhibits the reaction [Cadmium results in increased cleavage of PARP1 protein] | CTD | PMID:19433269 |
| lead diacetate | decreases expression | ISO | RGD:1551988 | 6480464 | lead acetate results in decreased expression of PARP1 mRNA | CTD | PMID:21829687 |
| lithium atom | multiple interactions | EXP | | 6480464 | Lithium inhibits the reaction [sodium arsenite results in increased cleavage of PARP1 protein] | CTD | PMID:17849503 |
| lithocholic acid | multiple interactions | EXP | | 6480464 | 3-aminobenzamide inhibits the reaction [Lithocholic Acid analog results in increased activity of PARP1 protein] | CTD | PMID:2120135 |
| lithocholic acid | increases activity | EXP | | 6480464 | Lithocholic Acid analog results in increased activity of PARP1 protein | CTD | PMID:2120135 |
| LY294002 | multiple interactions | ISO | RGD:1551988 | 6480464 | 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [cadmium sulfate results in increased cleavage of PARP1 protein] | CTD | PMID:14687664 |
| LY294002 | multiple interactions | EXP | | 6480464 | [2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [FAM168A results in decreased susceptibility to Cisplatin]] which results in increased cleavage of PARP1 protein | CTD | PMID:23251525 |
| LY294002 | multiple interactions | EXP | | 6480464 | 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one promotes the reaction [Capsaicin results in increased cleavage of and results in increased activity of PARP1 protein] | CTD | PMID:22226932 |
| LY294002 | multiple interactions | EXP | | 6480464 | [TNFSF10 protein co-treated with 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one] results in increased cleavage of PARP1 protein | CTD | PMID:19261616 |
| menadione | multiple interactions | EXP | | 6480464 | [sodium arsenite co-treated with Vitamin K 3] results in increased cleavage of PARP1 protein | CTD | PMID:19082730 |
| menadione | affects response to substance | ISO | RGD:1551988 | 6480464 | PARP1 protein affects the susceptibility to Vitamin K 3 | CTD | PMID:21124846 |
| mercury dichloride | increases cleavage | EXP | | 6480464 | Mercuric Chloride results in increased cleavage of PARP1 protein | CTD | PMID:12504520 more ... |
| mercury dichloride | multiple interactions | ISO | RGD:1551988 | 6480464 | Acetylcysteine inhibits the reaction [[Mercuric Chloride co-treated with prolinedithiocarbamate] results in increased degradation of PARP1 protein] | CTD | PMID:22909951 |
| mercury dichloride | increases cleavage | EXP | | 6480464 | Mercuric Chloride results in increased cleavage of PARP1 protein | CTD | PMID:11068922 more ... |
| mesalamine | increases cleavage | EXP | | 6480464 | Mesalamine results in increased cleavage of PARP1 protein | CTD | PMID:12663503 |
| methotrexate | increases cleavage | EXP | | 6480464 | Methotrexate results in increased cleavage of PARP1 protein | CTD | PMID:17286800 |
| methyl methanesulfonate | affects response to substance | EXP | | 6480464 | PARP1 protein affects the susceptibility to Methyl Methanesulfonate | CTD | PMID:19111594 |
| methylmercury chloride | increases cleavage | EXP | | 6480464 | methylmercuric chloride results in increased cleavage of PARP1 protein | CTD | PMID:11068922 |
| metipranolol | multiple interactions | ISO | RGD:2053 | 6480464 | Metipranolol inhibits the reaction [Zinc results in decreased expression of PARP1 protein]; more ... | CTD | PMID:16799065 |
| mevalonic acid | multiple interactions | EXP | | 6480464 | Mevalonic Acid inhibits the reaction [Simvastatin results in increased cleavage of PARP1 protein] | CTD | PMID:20045437 |
| mevalonic acid | multiple interactions | EXP | | 6480464 | Mevalonic Acid inhibits the reaction [Simvastatin promotes the reaction [TNFSF10 protein results in increased cleavage of PARP1 protein]]; more ... | CTD | PMID:21910007 |
| microcystin-LR | increases cleavage | ISO | RGD:1551988 | 6480464 | cyanoginosin LR results in increased cleavage of PARP1 protein | CTD | PMID:21684301 |
| microcystin-LR | multiple interactions | ISO | RGD:1551988 | 6480464 | sulforafan inhibits the reaction [cyanoginosin LR results in increased cleavage of PARP1 protein] | CTD | PMID:21684301 |
| mifepristone | multiple interactions | ISO | RGD:1551988 | 6480464 | Mifepristone inhibits the reaction [Dexamethasone results in increased cleavage of PARP1 protein] | CTD | PMID:16644695 |
| mifepristone | increases cleavage | EXP | | 6480464 | Mifepristone results in increased cleavage of PARP1 protein | CTD | PMID:16525653 |
| mitomycin C | multiple interactions | EXP | | 6480464 | Chloramphenicol inhibits the reaction [Mitomycin results in increased activity of PARP1 protein]; more ... | CTD | PMID:15905168 |
| mitomycin C | increases activity | EXP | | 6480464 | Mitomycin results in increased activity of PARP1 protein | CTD | PMID:15905168 |
| mitoxantrone | multiple interactions | EXP | | 6480464 | [Cladribine co-treated with Cyclophosphamide co-treated with Mitoxantrone] results in decreased expression of PARP1 protein | CTD | PMID:15582267 |
| myricetin | increases cleavage | EXP | | 6480464 | myricetin results in increased cleavage of PARP1 protein | CTD | PMID:15748703 |
| myricetin | decreases activity | EXP | | 6480464 | myricetin results in decreased activity of PARP1 protein | CTD | PMID:17884996 |
| N,N-dimethylformamide | multiple interactions | ISO | RGD:2053 | 6480464 | [Dimethylformamide co-treated with Carbon Tetrachloride] results in increased cleavage of PARP1 protein | CTD | PMID:20097184 |
| N-acetyl-L-cysteine | multiple interactions | ISO | RGD:1551988 | 6480464 | Acetylcysteine inhibits the reaction [cadmium sulfate results in increased cleavage of PARP1 protein] | CTD | PMID:14687664 |
| N-acetyl-L-cysteine | multiple interactions | ISO | RGD:2053 | 6480464 | Acetylcysteine inhibits the reaction [Chlorpyrifos results in increased cleavage of PARP1 protein] | CTD | PMID:22714038 |
| N-acetyl-L-cysteine | multiple interactions | ISO | RGD:1551988 | 6480464 | Acetylcysteine inhibits the reaction [[Mercuric Chloride co-treated with prolinedithiocarbamate] results in increased degradation of PARP1 protein] | CTD | PMID:22909951 |
| N-acetyl-L-cysteine | multiple interactions | ISO | RGD:1551988 | 6480464 | Acetylcysteine inhibits the reaction [arsenic trioxide results in increased cleavage of PARP1 protein] | CTD | PMID:21565247 |
| N-acetyl-L-cysteine | multiple interactions | EXP | | 6480464 | Acetylcysteine inhibits the reaction [Cadmium Chloride results in increased cleavage of and results in increased activity of PARP1 protein] | CTD | PMID:18703135 |
| N-acetyl-L-cysteine | multiple interactions | ISO | RGD:2053 | 6480464 | Acetylcysteine inhibits the reaction [Cadmium Chloride results in increased cleavage of and results in increased activity of PARP1 protein] | CTD | PMID:18703135 |
| N-acetyl-L-cysteine | multiple interactions | EXP | | 6480464 | Acetylcysteine results in decreased susceptibility to [1-(3',4',5'-trimethoxyphenyl)-3-(3'',4''-dimethoxy-2'-hydroxyphenyl)propane results in increased cleavage of PARP1 protein] | CTD | PMID:20674558 |
| N-acetyl-L-cysteine | increases cleavage | ISO | RGD:1551988 | 6480464 | Acetylcysteine results in increased cleavage of PARP1 protein | CTD | PMID:15375156 |
| N-acetyl-L-cysteine | multiple interactions | ISO | RGD:2053 | 6480464 | Acetylcysteine inhibits the reaction [Gentamicins results in increased activity of PARP1 protein] | CTD | PMID:11470263 |
| N-acetyl-L-cysteine | multiple interactions | EXP | | 6480464 | [Glucose deficiency co-treated with Acetylcysteine] results in increased cleavage of PARP1 protein | CTD | PMID:17309078 |
| N-acetyl-L-cysteine | multiple interactions | EXP | | 6480464 | Acetylcysteine inhibits the reaction [manumycin results in increased cleavage of PARP1] | CTD | PMID:19409983 |
| N-acetyl-L-cysteine | multiple interactions | EXP | | 6480464 | Acetylcysteine inhibits the reaction [Tosylphenylalanyl Chloromethyl Ketone results in increased cleavage of PARP1 protein] | CTD | PMID:19679660 |
| N-acetyl-L-cysteine | multiple interactions | EXP | | 6480464 | Acetylcysteine inhibits the reaction [[Sulindac co-treated with arsenic trioxide] results in increased cleavage of PARP1 protein] | CTD | PMID:18281123 |
| N-acetyl-L-cysteine | multiple interactions | EXP | | 6480464 | Acetylcysteine inhibits the reaction [shogaol results in increased cleavage of PARP1 protein] | CTD | PMID:18384088 |
| N-acetyl-L-cysteine | multiple interactions | EXP | | 6480464 | Acetylcysteine inhibits the reaction [Cisplatin results in increased cleavage of PARP1 protein] | CTD | PMID:15496615 |
| N-acetyl-L-cysteine | multiple interactions | EXP | | 6480464 | Acetylcysteine inhibits the reaction [2'-benzoyloxycinnamaldehyde results in increased cleavage of PARP1 protein] | CTD | PMID:14660655 |
| N-acetyl-L-cysteine | multiple interactions | EXP | | 6480464 | Acetylcysteine inhibits the reaction [[arsenic trioxide co-treated with phytosphingosine] results in increased activity of PARP1 protein] | CTD | PMID:17237268 |
| N-methyl-N'-nitro-N-nitrosoguanidine | multiple interactions | ISO | RGD:1551988 | 6480464 | [benzamide results in decreased activity of PARP1 protein] which results in decreased susceptibility to Methylnitronitrosoguanidine; more ... | CTD | PMID:11593040 |
| N-methyl-N'-nitro-N-nitrosoguanidine | increases response to substance | EXP | | 6480464 | PARP1 protein results in increased susceptibility to Methylnitronitrosoguanidine | CTD | PMID:22001597 |
| N-methyl-N'-nitro-N-nitrosoguanidine | affects cleavage | ISO | RGD:1551988 | 6480464 | Methylnitronitrosoguanidine affects the cleavage of PARP1 protein | CTD | PMID:20434464 |
| N-methyl-N'-nitro-N-nitrosoguanidine | multiple interactions | ISO | RGD:1551988 | 6480464 | Eugenol affects the reaction [Methylnitronitrosoguanidine affects the cleavage of PARP1 protein] | CTD | PMID:20434464 |
| N-methyl-N'-nitro-N-nitrosoguanidine | increases activity | ISO | RGD:1551988 | 6480464 | Methylnitronitrosoguanidine results in increased activity of PARP1 protein | CTD | PMID:11593040 |
| N-methyl-N-nitrosurea | increases response to substance | ISO | RGD:1551988 | 6480464 | PARP1 gene mutant form results in increased susceptibility to Methylnitrosourea | CTD | PMID:15282315 |
| N-methyl-N-nitrosurea | multiple interactions | ISO | RGD:2053 | 6480464 | Niacinamide inhibits the reaction [Methylnitrosourea results in increased activity of PARP1 protein] | CTD | PMID:16168987 |
| N-methyl-N-nitrosurea | increases activity | ISO | RGD:2053 | 6480464 | Methylnitrosourea results in increased activity of PARP1 protein | CTD | PMID:16168987 |
| N-methyl-N-nitrosurea | multiple interactions | ISO | RGD:1551988 | 6480464 | PARP1 protein promotes the reaction [Methylnitrosourea affects the metabolism of SOD2 protein] | CTD | PMID:16052507 |
| N-methyl-N-nitrosurea | affects response to substance | ISO | RGD:1551988 | 6480464 | PARP1 protein affects the susceptibility to Methylnitrosourea | CTD | PMID:11850828 |
| N-methyl-N-nitrosurea | multiple interactions | ISO | RGD:1551988 | 6480464 | PARP1 protein affects the reaction [Methylnitrosourea affects the activity of TRP53 protein]; more ... | CTD | PMID:11850828 |
| N-nitrosodiethylamine | multiple interactions | ISO | RGD:2053 | 6480464 | [Diethylnitrosamine co-treated with Clofibric Acid] affects the expression of PARP1 mRNA | CTD | PMID:17602206 |
| N-tosyl-L-phenylalanyl chloromethyl ketone | multiple interactions | EXP | | 6480464 | Acetylcysteine inhibits the reaction [Tosylphenylalanyl Chloromethyl Ketone results in increased cleavage of PARP1 protein] | CTD | PMID:19679660 |
| N-tosyl-L-phenylalanyl chloromethyl ketone | increases cleavage | EXP | | 6480464 | Tosylphenylalanyl Chloromethyl Ketone results in increased cleavage of PARP1 protein | CTD | PMID:19679660 |
| NAD zwitterion | multiple interactions | EXP | | 6480464 | [3-aminobenzamide results in decreased activity of PARP1 protein] inhibits the reaction [Tetrachlorodibenzodioxin results in decreased abundance of NAD]; more ... | CTD | PMID:17669606 |
| NAD zwitterion | multiple interactions | EXP | | 6480464 | [2,5,2',5'-tetrachlorobiphenyl results in increased activity of PARP1 protein] which results in decreased abundance of NAD; more ... | CTD | PMID:19433264 |
| NAD zwitterion | affects abundance | ISO | RGD:2053 | 6480464 | PARP1 protein affects the abundance of NAD | CTD | PMID:15147502 |
| NAD zwitterion | multiple interactions | ISO | RGD:1551988 | 6480464 | benzamide inhibits the reaction [[Hydrogen Peroxide results in increased activity of PARP1 protein] which results in decreased abundance of NAD]; more ... | CTD | PMID:11593040 |
| NAD(+) | multiple interactions | EXP | | 6480464 | [3-aminobenzamide results in decreased activity of PARP1 protein] inhibits the reaction [Tetrachlorodibenzodioxin results in decreased abundance of NAD]; more ... | CTD | PMID:17669606 |
| NAD(+) | multiple interactions | EXP | | 6480464 | [2,5,2',5'-tetrachlorobiphenyl results in increased activity of PARP1 protein] which results in decreased abundance of NAD; more ... | CTD | PMID:19433264 |
| NAD(+) | affects abundance | ISO | RGD:2053 | 6480464 | PARP1 protein affects the abundance of NAD | CTD | PMID:15147502 |
| NAD(+) | multiple interactions | ISO | RGD:1551988 | 6480464 | benzamide inhibits the reaction [[Hydrogen Peroxide results in increased activity of PARP1 protein] which results in decreased abundance of NAD]; more ... | CTD | PMID:11593040 |
| NADP zwitterion | multiple interactions | EXP | | 6480464 | [3-aminobenzamide results in decreased activity of PARP1 protein] inhibits the reaction [Tetrachlorodibenzodioxin results in decreased abundance of NADP]; more ... | CTD | PMID:17669606 |
| NADP(+) | multiple interactions | EXP | | 6480464 | [3-aminobenzamide results in decreased activity of PARP1 protein] inhibits the reaction [Tetrachlorodibenzodioxin results in decreased abundance of NADP]; more ... | CTD | PMID:17669606 |
| nickel dichloride | increases cleavage | EXP | | 6480464 | nickel chloride results in increased cleavage of PARP1 protein | CTD | PMID:21828359 |
| nickel dichloride | increases cleavage | ISO | RGD:2053 | 6480464 | nickel chloride results in increased cleavage of PARP1 protein | CTD | PMID:21843586 |
| nickel dichloride | multiple interactions | ISO | RGD:2053 | 6480464 | anthra(1,9-cd)pyrazol-6(2H)-one inhibits the reaction [nickel chloride results in increased cleavage of PARP1 protein] | CTD | PMID:21843586 |
| nickel sulfate | increases cleavage | EXP | | 6480464 | nickel sulfate results in increased cleavage of PARP1 protein | CTD | PMID:19135467 |
| nickel sulfate | increases cleavage | ISO | RGD:2053 | 6480464 | nickel sulfate results in increased cleavage of PARP1 protein | CTD | PMID:19135467 |
| nicotinamide | multiple interactions | ISO | RGD:2053 | 6480464 | Niacinamide inhibits the reaction [Methylnitrosourea results in increased activity of PARP1 protein] | CTD | PMID:16168987 |
| nicotinamide | multiple interactions | ISO | RGD:2053 | 6480464 | Niacinamide inhibits the reaction [Excitatory Amino Acid Agonists results in decreased expression of PARP1 protein]; more ... | CTD | PMID:19288225 |
| nicotinamide | decreases activity | ISO | RGD:2053 | 6480464 | Niacinamide results in decreased activity of PARP1 protein | CTD | PMID:19288225 |
| nicotinamide | multiple interactions | ISO | RGD:2053 | 6480464 | Niacinamide inhibits the reaction [Thiotepa results in increased cleavage of PARP1 protein] | CTD | PMID:22164206 |
| nicotinic acid | multiple interactions | EXP | | 6480464 | [Niacin co-treated with Ubiquinone co-treated with Riboflavin] results in increased expression of PARP1 protein | CTD | PMID:18377693 |
| nicotinic acid | multiple interactions | ISO | RGD:2053 | 6480464 | Niacin deficiency affects the reaction [Etoposide results in increased cleavage of PARP1 protein] | CTD | PMID:17516866 |
| nimesulide | increases cleavage | EXP | | 6480464 | nimesulide results in increased cleavage of PARP1 protein | CTD | PMID:19360361 |
| nitric oxide | multiple interactions | EXP | | 6480464 | [S-Nitroso-N-Acetylpenicillamine results in increased abundance of Nitric Oxide] inhibits the reaction [N-caproylsphingosine promotes the reaction [CASP3 protein results in increased cleavage of PARP1 protein]] | CTD | PMID:10811113 |
| nitric oxide | increases cleavage | EXP | | 6480464 | Nitric Oxide results in increased cleavage of PARP1 protein | CTD | PMID:16024610 PMID:15126337 |
| nitric oxide | increases cleavage | EXP | | 6480464 | Nitric Oxide results in increased cleavage of PARP1 protein | CTD | PMID:15126337 PMID:16024610 |
| nitroglycerin | decreases expression | EXP | | 6480464 | Nitroglycerin results in decreased expression of PARP1 protein alternative form | CTD | PMID:17322376 |
| NMN zwitterion | affects abundance | EXP | | 6480464 | PARP1 protein affects the abundance of Nicotinamide Mononucleotide | CTD | PMID:19426698 |
| nocodazole | increases cleavage | EXP | | 6480464 | Nocodazole results in increased cleavage of PARP1 protein | CTD | PMID:15907805 |
| nocodazole | increases cleavage | EXP | | 6480464 | Nocodazole results in increased cleavage of PARP1 protein | CTD | PMID:15907805 PMID:21903591 |
| nocodazole | multiple interactions | EXP | | 6480464 | TYMP inhibits the reaction [Nocodazole results in increased cleavage of PARP1 protein] | CTD | PMID:15907805 |
| okadaic acid | multiple interactions | EXP | | 6480464 | Okadaic Acid inhibits the reaction [Amiloride promotes the reaction [TNFSF10 protein results in increased cleavage of PARP1 protein]] | CTD | PMID:16059913 |
| oleic acid | increases cleavage | EXP | | 6480464 | Oleic Acid results in increased cleavage of PARP1 protein | CTD | PMID:21132278 |
| omeprazole | increases cleavage | EXP | | 6480464 | Omeprazole results in increased cleavage of PARP1 protein | CTD | PMID:15461867 |
| oroxylin A | increases degradation | EXP | | 6480464 | 5,7-dihydroxy-6-methoxy-2-phenylchromen-4-one results in increased degradation of PARP1 protein | CTD | PMID:19135124 |
| oxaliplatin | multiple interactions | EXP | | 6480464 | [oxaliplatin co-treated with Ursodeoxycholic Acid] results in increased cleavage of PARP1 protein | CTD | PMID:19728331 |
| oxaliplatin | increases cleavage | EXP | | 6480464 | oxaliplatin results in increased cleavage of PARP1 protein | CTD | PMID:16243822 |
| oxaliplatin | multiple interactions | EXP | | 6480464 | gefitinib affects the reaction [oxaliplatin results in increased cleavage of PARP1 protein] | CTD | PMID:16243822 |
| paclitaxel | multiple interactions | EXP | | 6480464 | AKT1 protein affects the reaction [Paclitaxel results in increased cleavage of PARP1 protein]; more ... | CTD | PMID:10075725 |
| paclitaxel | increases cleavage | EXP | | 6480464 | Paclitaxel results in increased cleavage of PARP1 protein | CTD | PMID:10075725 more ... |
| paclitaxel | increases cleavage | EXP | | 6480464 | Paclitaxel results in increased cleavage of PARP1 protein | CTD | PMID:10075725 more ... |
| paclitaxel | increases cleavage | EXP | | 6480464 | Paclitaxel results in increased cleavage of PARP1 protein | CTD | PMID:15585644 more ... |
| paclitaxel | increases cleavage | EXP | | 6480464 | Paclitaxel results in increased cleavage of PARP1 protein | CTD | PMID:18071906 more ... |
| paclitaxel | increases cleavage | EXP | | 6480464 | Paclitaxel results in increased cleavage of PARP1 protein | CTD | PMID:10430095 more ... |
| paclitaxel | increases cleavage | EXP | | 6480464 | Paclitaxel results in increased cleavage of PARP1 protein | CTD | PMID:11774260 more ... |
| paclitaxel | increases cleavage | EXP | | 6480464 | Paclitaxel results in increased cleavage of PARP1 protein | CTD | PMID:10075725 more ... |
| paclitaxel | multiple interactions | EXP | | 6480464 | TYMP mutant form promotes the reaction [Paclitaxel results in increased cleavage of PARP1 protein] | CTD | PMID:15492279 |
| paclitaxel | multiple interactions | EXP | | 6480464 | TYMP inhibits the reaction [Paclitaxel results in increased cleavage of PARP1 protein] | CTD | PMID:15907805 |
| paclitaxel | multiple interactions | EXP | | 6480464 | [resveratrol co-treated with Paclitaxel] results in increased cleavage of PARP1 protein | CTD | PMID:14749477 |
| paclitaxel | increases cleavage | EXP | | 6480464 | Paclitaxel results in increased cleavage of PARP1 protein | CTD | PMID:10430095 more ... |
| paclitaxel | multiple interactions | EXP | | 6480464 | flavopiridol promotes the reaction [Paclitaxel results in increased cleavage of PARP1 protein]; more ... | CTD | PMID:10430095 |
| paclitaxel | multiple interactions | EXP | | 6480464 | [3,3'-diindolylmethane co-treated with Paclitaxel] results in increased cleavage of and results in increased activity of PARP1 protein | CTD | PMID:16580691 |
| paracetamol | increases cleavage | EXP | | 6480464 | Acetaminophen results in increased cleavage of PARP1 | CTD | PMID:12005112 |
| paracetamol | decreases expression | EXP | | 6480464 | Acetaminophen results in decreased expression of PARP1 mRNA | CTD | PMID:21420995 |
| paracetamol | increases expression | ISO | RGD:2053 | 6480464 | Acetaminophen results in increased expression of PARP1 mRNA | CTD | PMID:16751229 |
| paracetamol | increases response to substance | ISO | RGD:1551988 | 6480464 | PARP1 protein results in increased susceptibility to Acetaminophen | CTD | PMID:15601672 |
| paracetamol | increases activity | ISO | RGD:1551988 | 6480464 | Acetaminophen results in increased activity of PARP1 protein | CTD | PMID:15601672 |
| paracetamol | multiple interactions | ISO | RGD:1551988 | 6480464 | 3-aminobenzamide inhibits the reaction [PARP1 protein results in increased susceptibility to Acetaminophen]; more ... | CTD | PMID:15601672 |
| paracetamol | increases cleavage | EXP | | 6480464 | Acetaminophen results in increased cleavage of PARP1 protein | CTD | PMID:14725611 |
| paraquat | multiple interactions | EXP | | 6480464 | [Antimycin A co-treated with Paraquat] results in increased cleavage of PARP1 protein; more ... | CTD | PMID:16237197 |
| paraquat | multiple interactions | EXP | | 6480464 | [PTGDS protein results in decreased susceptibility to Paraquat] which results in decreased cleavage of PARP1 protein; more ... | CTD | PMID:22043816 |
| paraquat | increases cleavage | EXP | | 6480464 | Paraquat results in increased cleavage of PARP1 protein | CTD | PMID:17018646 PMID:22043816 |
| paraquat | multiple interactions | ISO | RGD:1551988 | 6480464 | PARK7 protein affects the reaction [Paraquat results in increased cleavage of PARP1 protein] | CTD | PMID:21300143 |
| paraquat | increases cleavage | ISO | RGD:1551988 | 6480464 | Paraquat results in increased cleavage of PARP1 protein | CTD | PMID:21300143 |
| paraquat | increases cleavage | EXP | | 6480464 | Paraquat results in increased cleavage of PARP1 protein | CTD | PMID:17018646 |
| pentetic acid | multiple interactions | EXP | | 6480464 | Pentetic Acid inhibits the reaction [zinc pyrithione results in increased activity of PARP1 protein]; more ... | CTD | PMID:21424779 |
| phenanthrene | increases cleavage | EXP | | 6480464 | phenanthrene results in increased cleavage of PARP1 protein | CTD | PMID:21132278 |
| phenobarbital | increases expression | ISO | RGD:2053 | 6480464 | Phenobarbital results in increased expression of PARP1 mRNA | CTD | PMID:19162173 |
| phenobarbital | affects expression | EXP | | 6480464 | Phenobarbital affects the expression of PARP1 mRNA | CTD | PMID:19159669 |
| phenylephrine | multiple interactions | ISO | RGD:2053 | 6480464 | Phenylephrine inhibits the reaction [Oxygen deficiency results in increased cleavage of PARP1 protein] | CTD | PMID:11042672 |
| phloroglucinol | increases cleavage | EXP | | 6480464 | Phloroglucinol analog results in increased cleavage of PARP1 protein | CTD | PMID:23178381 |
| phloroglucinol | increases cleavage | EXP | | 6480464 | Phloroglucinol metabolite results in increased cleavage of PARP1 protein | CTD | PMID:22796323 |
| phorbol 13-acetate 12-myristate | multiple interactions | EXP | | 6480464 | 3-aminobenzamide inhibits the reaction [Tetradecanoylphorbol Acetate results in increased activity of PARP1 protein] | CTD | PMID:2120135 PMID:2126186 |
| phorbol 13-acetate 12-myristate | affects response to substance | EXP | | 6480464 | PARP1 protein affects the susceptibility to Tetradecanoylphorbol Acetate | CTD | PMID:16323285 |
| phorbol 13-acetate 12-myristate | multiple interactions | EXP | | 6480464 | 3-aminobenzamide inhibits the reaction [Tetradecanoylphorbol Acetate results in increased activity of PARP1 protein] | CTD | PMID:2126186 PMID:2120135 |
| phorbol 13-acetate 12-myristate | increases activity | EXP | | 6480464 | Tetradecanoylphorbol Acetate results in increased activity of PARP1 protein | CTD | PMID:2120135 PMID:2126186 |
| phorbol 13-acetate 12-myristate | increases activity | EXP | | 6480464 | Tetradecanoylphorbol Acetate results in increased activity of PARP1 protein | CTD | PMID:2126186 PMID:2120135 |
| phorbol 13-acetate 12-myristate | multiple interactions | EXP | | 6480464 | [Glucose deficiency co-treated with Tetradecanoylphorbol Acetate] results in increased cleavage of PARP1 protein | CTD | PMID:17309078 |
| phorbol 13-acetate 12-myristate | multiple interactions | EXP | | 6480464 | Butylated Hydroxytoluene inhibits the reaction [Tetradecanoylphorbol Acetate results in increased activity of PARP1 protein]; more ... | CTD | PMID:2126186 |
| phytosphingosine | multiple interactions | EXP | | 6480464 | 3,4-dihydro-5-(4-(1-piperidinyl)butoxy)-1(2H)-isoquinolinone inhibits the reaction [[arsenic trioxide co-treated with phytosphingosine] results in increased activity of PARP1 protein]; more ... | CTD | PMID:17237268 |
| phytosphingosine | increases activity | EXP | | 6480464 | phytosphingosine results in increased activity of PARP1 protein | CTD | PMID:15486061 |
| pirinixic acid | increases expression | ISO | RGD:1551988 | 6480464 | pirinixic acid results in increased expression of PARP1 mRNA | CTD | PMID:18301758 |
| pirinixic acid | decreases expression | ISO | RGD:2053 | 6480464 | pirinixic acid results in decreased expression of PARP1 mRNA | CTD | PMID:16940010 |
| platinum | multiple interactions | EXP | | 6480464 | Cisplatin promotes the reaction [Platinum binds to PARP1 protein] | CTD | PMID:21370912 |
| platinum(0) | multiple interactions | EXP | | 6480464 | Cisplatin promotes the reaction [Platinum binds to PARP1 protein] | CTD | PMID:21370912 |
| potassium dichromate | multiple interactions | ISO | RGD:2053 | 6480464 | Ascorbic Acid inhibits the reaction [Potassium Dichromate results in increased cleavage of PARP1 protein] | CTD | PMID:21262251 |
| potassium dichromate | increases cleavage | ISO | RGD:2053 | 6480464 | Potassium Dichromate results in increased cleavage of PARP1 protein | CTD | PMID:21262251 |
| prostaglandin D2 | increases cleavage | EXP | | 6480464 | Prostaglandin D2 results in increased cleavage of PARP1 protein | CTD | PMID:15843042 |
| prostaglandin E2 | multiple interactions | EXP | | 6480464 | Dinoprostone inhibits the reaction [icarisid II results in increased cleavage of PARP1 protein] | CTD | PMID:19289254 |
| prostaglandin J2 | increases cleavage | EXP | | 6480464 | 9-deoxy-delta-9-prostaglandin D2 results in increased cleavage of PARP1 protein | CTD | PMID:15843042 |
| pterostilbene | increases expression | EXP | | 6480464 | pterostilbene results in increased expression of PARP1 protein modified form | CTD | PMID:19549798 |
| pyrene | increases cleavage | EXP | | 6480464 | pyrene results in increased cleavage of PARP1 protein | CTD | PMID:21132278 |
| pyridaben | increases cleavage | EXP | | 6480464 | pyridaben results in increased cleavage of PARP1 protein | CTD | PMID:16237197 |
| pyridaben | multiple interactions | EXP | | 6480464 | [pyridaben co-treated with Paraquat] results in increased cleavage of PARP1 protein | CTD | PMID:16237197 |
| quercetin | multiple interactions | EXP | | 6480464 | Quercetin promotes the reaction [TNFSF10 protein results in increased cleavage of PARP1 protein] | CTD | PMID:17876056 PMID:18377872 |
| quercetin | multiple interactions | EXP | | 6480464 | Quercetin promotes the reaction [TNFSF10 protein results in increased cleavage of PARP1 protein] | CTD | PMID:18377872 PMID:17876056 |
| quercetin | increases cleavage | EXP | | 6480464 | Quercetin results in increased cleavage of PARP1 protein | CTD | PMID:15741050 PMID:18787224 |
| quercetin | multiple interactions | ISO | RGD:1551988 | 6480464 | Quercetin inhibits the reaction [Hydrogen Peroxide results in increased cleavage of PARP1 protein] | CTD | PMID:15876423 |
| quercetin | decreases expression | ISO | RGD:1551988 | 6480464 | Quercetin results in decreased expression of PARP1 protein | CTD | PMID:17039455 |
| quercetin | increases degradation | EXP | | 6480464 | Quercetin results in increased degradation of PARP1 protein | CTD | PMID:16059641 |
| quercetin | increases cleavage | EXP | | 6480464 | Quercetin results in increased cleavage of PARP1 protein | CTD | PMID:18787224 PMID:15741050 |
| quercetin | decreases activity | EXP | | 6480464 | Quercetin results in decreased activity of PARP1 protein | CTD | PMID:17884996 |
| quercetin | increases expression | EXP | | 6480464 | Quercetin metabolite results in increased expression of PARP1 protein | CTD | PMID:16280456 |
| ranitidine | multiple interactions | EXP | | 6480464 | Ranitidine inhibits the reaction [Rotenone results in increased cleavage of PARP1 protein] | CTD | PMID:19723537 |
| resveratrol | increases cleavage | EXP | | 6480464 | resveratrol results in increased cleavage of PARP1 protein | CTD | PMID:12690110 more ... |
| resveratrol | increases cleavage | EXP | | 6480464 | resveratrol results in increased cleavage of PARP1 protein | CTD | PMID:12690110 more ... |
| resveratrol | multiple interactions | EXP | | 6480464 | [Coumestrol co-treated with resveratrol] results in increased expression of PARP1 mRNA | CTD | PMID:19167446 |
| resveratrol | increases cleavage | ISO | RGD:1551988 | 6480464 | resveratrol results in increased cleavage of PARP1 protein | CTD | PMID:16675471 more ... |
| resveratrol | increases degradation | EXP | | 6480464 | resveratrol results in increased degradation of PARP1 protein | CTD | PMID:20028382 |
| resveratrol | multiple interactions | EXP | | 6480464 | [resveratrol results in increased activity of CASP3 protein] which results in increased cleavage of PARP1 protein | CTD | PMID:19561642 |
| resveratrol | increases cleavage | EXP | | 6480464 | resveratrol results in increased cleavage of PARP1 protein | CTD | PMID:16617056 more ... |
| resveratrol | increases cleavage | EXP | | 6480464 | resveratrol results in increased cleavage of PARP1 protein | CTD | PMID:16617056 more ... |
| resveratrol | increases cleavage | EXP | | 6480464 | resveratrol results in increased cleavage of PARP1 protein | CTD | PMID:17164350 more ... |
| resveratrol | increases cleavage | EXP | | 6480464 | resveratrol results in increased cleavage of PARP1 protein | CTD | PMID:16814113 more ... |
| resveratrol | increases expression | EXP | | 6480464 | resveratrol results in increased expression of PARP1 protein modified form | CTD | PMID:9680369 |
| resveratrol | increases cleavage | EXP | | 6480464 | resveratrol results in increased cleavage of PARP1 protein | CTD | PMID:19631782 more ... |
| resveratrol | increases cleavage | ISO | RGD:1551988 | 6480464 | resveratrol results in increased cleavage of PARP1 protein | CTD | PMID:16675471 PMID:17872969 |
| resveratrol | increases cleavage | EXP | | 6480464 | resveratrol results in increased cleavage of PARP1 protein | CTD | PMID:17554206 more ... |
| resveratrol | increases cleavage | EXP | | 6480464 | resveratrol results in increased cleavage of PARP1 protein | CTD | PMID:17554206 more ... |
| resveratrol | multiple interactions | EXP | | 6480464 | resveratrol inhibits the reaction [IL1B protein results in increased cleavage of PARP1 protein] | CTD | PMID:17404069 PMID:17959154 |
| resveratrol | increases cleavage | EXP | | 6480464 | resveratrol results in increased cleavage of PARP1 protein | CTD | PMID:16617056 more ... |
| resveratrol | multiple interactions | EXP | | 6480464 | resveratrol promotes the reaction [TNFSF10 protein results in increased cleavage of PARP1 protein] | CTD | PMID:17823925 |
| resveratrol | multiple interactions | EXP | | 6480464 | resveratrol inhibits the reaction [IL1B protein results in increased cleavage of PARP1 protein] | CTD | PMID:17959154 PMID:17404069 |
| resveratrol | multiple interactions | EXP | | 6480464 | [resveratrol co-treated with Paclitaxel] results in increased cleavage of PARP1 protein | CTD | PMID:14749477 |
| resveratrol | multiple interactions | EXP | | 6480464 | resveratrol inhibits the reaction [Dopamine results in increased cleavage of PARP1 protein] | CTD | PMID:17603292 |
| resveratrol | multiple interactions | EXP | | 6480464 | BCL2 protein inhibits the reaction [resveratrol results in increased cleavage of PARP1 protein]; more ... | CTD | PMID:19631782 |
| resveratrol | increases cleavage | ISO | RGD:1551988 | 6480464 | resveratrol results in increased cleavage of PARP1 protein | CTD | PMID:17872969 PMID:16675471 |
| resveratrol | multiple interactions | EXP | | 6480464 | [resveratrol results in increased activity of SIRT1 protein] which results in decreased activity of PARP1 protein | CTD | PMID:16628003 |
| resveratrol | multiple interactions | ISO | RGD:1551988 | 6480464 | resveratrol inhibits the reaction [PPT1 gene mutant form results in increased expression of PARP1 protein modified form] | CTD | PMID:21224254 |
| riboflavin | multiple interactions | EXP | | 6480464 | [Niacin co-treated with Ubiquinone co-treated with Riboflavin] results in increased expression of PARP1 protein | CTD | PMID:18377693 |
| riboflavin | increases cleavage | ISO | RGD:1551988 | 6480464 | Riboflavin analog results in increased cleavage of PARP1 protein | CTD | PMID:20688149 |
| romidepsin | multiple interactions | EXP | | 6480464 | bortezomib promotes the reaction [romidepsin results in increased cleavage of PARP1 protein] | CTD | PMID:18223231 |
| romidepsin | increases cleavage | EXP | | 6480464 | romidepsin results in increased cleavage of PARP1 protein | CTD | PMID:18223231 |
| rotenone | multiple interactions | EXP | | 6480464 | anthra(1,9-cd)pyrazol-6(2H)-one inhibits the reaction [Rotenone results in increased cleavage of PARP1 protein]; more ... | CTD | PMID:19777565 |
| rotenone | increases cleavage | EXP | | 6480464 | Rotenone results in increased cleavage of PARP1 protein | CTD | PMID:14976342 more ... |
| rotenone | multiple interactions | EXP | | 6480464 | Ranitidine inhibits the reaction [Rotenone results in increased cleavage of PARP1 protein] | CTD | PMID:19723537 |
| rotenone | increases cleavage | EXP | | 6480464 | Rotenone results in increased cleavage of PARP1 protein | CTD | PMID:14976342 more ... |
| rotenone | increases cleavage | EXP | | 6480464 | Rotenone results in increased cleavage of PARP1 protein | CTD | PMID:19682553 more ... |
| rotenone | increases cleavage | EXP | | 6480464 | Rotenone results in increased cleavage of PARP1 protein | CTD | PMID:19682553 more ... |
| rotenone | multiple interactions | EXP | | 6480464 | Tranexamic Acid inhibits the reaction [Rotenone results in increased cleavage of PARP1 protein] | CTD | PMID:19539006 |
| rotenone | increases cleavage | EXP | | 6480464 | Rotenone results in increased cleavage of PARP1 protein | CTD | PMID:19682553 more ... |
| rotenone | increases cleavage | EXP | | 6480464 | Rotenone results in increased cleavage of PARP1 protein | CTD | PMID:19777565 more ... |
| rotenone | increases cleavage | EXP | | 6480464 | Rotenone results in increased cleavage of PARP1 protein | CTD | PMID:14976342 more ... |
| rotenone | increases cleavage | EXP | | 6480464 | Rotenone results in increased cleavage of PARP1 protein | CTD | PMID:19682553 more ... |
| rotenone | multiple interactions | EXP | | 6480464 | ATG5 protein affects the reaction [Sirolimus inhibits the reaction [Rotenone results in increased cleavage of PARP1 protein]] | CTD | PMID:19682553 |
| rotenone | multiple interactions | EXP | | 6480464 | aspartyl-glutamyl-valyl-aspartal inhibits the reaction [Rotenone results in increased cleavage of PARP1 protein] | CTD | PMID:14976342 |
| ruthenium atom | multiple interactions | EXP | | 6480464 | imidazolium-bis(imidazole)dimethylsulfoxideimidazotetrachlororuthenate(III) promotes the reaction [Ruthenium binds to PARP1 protein]; more ... | CTD | PMID:21370912 |
| S-(1,2-dichlorovinyl)-L-cysteine | increases cleavage | EXP | | 6480464 | S-(1,2-dichlorovinyl)cysteine results in increased cleavage of PARP1 protein | CTD | PMID:15967204 |
| selenium atom | multiple interactions | EXP | | 6480464 | AKT1 protein modified form inhibits the reaction [[Doxorubicin co-treated with Selenium] results in increased degradation of PARP1 protein]; more ... | CTD | PMID:17339365 |
| serotonin | affects abundance | EXP | | 6480464 | PARP1 affects the abundance of Serotonin | CTD | PMID:21990073 |
| silicon dioxide | multiple interactions | EXP | | 6480464 | decitabine inhibits the reaction [Silicon Dioxide results in decreased expression of PARP1 mRNA] | CTD | PMID:20123007 |
| silicon dioxide | increases methylation | EXP | | 6480464 | Silicon Dioxide results in increased methylation of PARP1 promoter | CTD | PMID:22265868 |
| silicon dioxide | multiple interactions | EXP | | 6480464 | DNMT1 protein promotes the reaction [Silicon Dioxide results in increased methylation of PARP1 promoter] | CTD | PMID:22265868 |
| silicon dioxide | decreases expression | EXP | | 6480464 | Silicon Dioxide results in decreased expression of PARP1 protein | CTD | PMID:22265868 |
| silicon dioxide | decreases expression | EXP | | 6480464 | Silicon Dioxide results in decreased expression of PARP1 mRNA | CTD | PMID:20123007 PMID:22265868 |
| silicon dioxide | decreases expression | EXP | | 6480464 | Silicon Dioxide results in decreased expression of PARP1 mRNA | CTD | PMID:20123007 |
| silymarin | multiple interactions | EXP | | 6480464 | pifithrin inhibits the reaction [silybin results in increased cleavage of PARP1 protein]; more ... | CTD | PMID:16777994 |
| simvastatin | multiple interactions | EXP | | 6480464 | Mevalonic Acid inhibits the reaction [Simvastatin results in increased cleavage of PARP1 protein]; more ... | CTD | PMID:20045437 |
| simvastatin | increases cleavage | EXP | | 6480464 | Simvastatin results in increased cleavage of PARP1 protein | CTD | PMID:20045437 more ... |
| simvastatin | multiple interactions | EXP | | 6480464 | Mevalonic Acid inhibits the reaction [Simvastatin promotes the reaction [TNFSF10 protein results in increased cleavage of PARP1 protein]]; more ... | CTD | PMID:21910007 |
| simvastatin | increases cleavage | EXP | | 6480464 | Simvastatin results in increased cleavage of PARP1 protein | CTD | PMID:20045437 PMID:20464445 |
| simvastatin | multiple interactions | ISO | RGD:2053 | 6480464 | Simvastatin inhibits the reaction [Glucose results in increased activity of PARP1 protein] | CTD | PMID:18004065 |
| simvastatin | decreases cleavage | ISO | RGD:2053 | 6480464 | Simvastatin results in decreased cleavage of PARP1 mRNA | CTD | PMID:16054375 |
| simvastatin | increases cleavage | EXP | | 6480464 | Simvastatin results in increased cleavage of PARP1 protein | CTD | PMID:20464445 PMID:20045437 |
| simvastatin | increases cleavage | EXP | | 6480464 | Simvastatin results in increased cleavage of PARP1 protein | CTD | PMID:20045437 |
| sirolimus | multiple interactions | EXP | | 6480464 | ATG5 protein affects the reaction [Sirolimus inhibits the reaction [Rotenone results in increased cleavage of PARP1 protein]] | CTD | PMID:19682553 |
| sirolimus | multiple interactions | EXP | | 6480464 | Sirolimus inhibits the reaction [Ethanol results in increased cleavage of PARP1 protein] | CTD | PMID:21410490 |
| skatole | increases cleavage | EXP | | 6480464 | Skatole results in increased cleavage of PARP1 protein | CTD | PMID:19700606 |
| sodium dichromate | multiple interactions | ISO | RGD:1551988 | 6480464 | CAT protein inhibits the reaction [sodium bichromate results in increased cleavage of PARP1 protein]; more ... | CTD | PMID:20298709 |
| sodium dichromate | increases expression | ISO | RGD:1551988 | 6480464 | sodium bichromate results in increased expression of PARP1 mRNA | CTD | PMID:22155349 |
| sodium dichromate | increases cleavage | ISO | RGD:1551988 | 6480464 | sodium bichromate results in increased cleavage of PARP1 protein | CTD | PMID:20298709 |
| staurosporine | increases cleavage | EXP | | 6480464 | Staurosporine results in increased cleavage of PARP1 protein | CTD | PMID:18451153 PMID:21447800 |
| staurosporine | multiple interactions | ISO | RGD:1551988 | 6480464 | Staurosporine affects the reaction [sodium arsenite results in increased cleavage of PARP1 protein] | CTD | PMID:11035063 |
| staurosporine | increases cleavage | ISO | RGD:1551988 | 6480464 | Staurosporine results in increased cleavage of PARP1 protein | CTD | PMID:10704466 PMID:11035063 |
| staurosporine | increases cleavage | EXP | | 6480464 | Staurosporine results in increased cleavage of PARP1 protein | CTD | PMID:21447800 PMID:18451153 |
| styrene oxide | increases cleavage | EXP | | 6480464 | styrene oxide results in increased cleavage of PARP1 protein | CTD | PMID:11929631 |
| styrene oxide | increases cleavage | ISO | RGD:1551988 | 6480464 | styrene oxide results in increased cleavage of PARP1 protein | CTD | PMID:17662326 |
| sulforaphane | multiple interactions | ISO | RGD:1551988 | 6480464 | sulforafan inhibits the reaction [cyanoginosin LR results in increased cleavage of PARP1 protein] | CTD | PMID:21684301 |
| sulindac | multiple interactions | EXP | | 6480464 | Acetylcysteine inhibits the reaction [[Sulindac co-treated with arsenic trioxide] results in increased cleavage of PARP1 protein]; more ... | CTD | PMID:18281123 |
| sulindac | increases activity | EXP | | 6480464 | Sulindac results in increased activity of PARP1 protein | CTD | PMID:15713900 |
| tamoxifen | multiple interactions | EXP | | 6480464 | alpha-Tocopherol inhibits the reaction [Tamoxifen results in increased cleavage of PARP1 protein]; more ... | CTD | PMID:14645110 |
| tamoxifen | increases cleavage | EXP | | 6480464 | Tamoxifen results in increased cleavage of PARP1 protein | CTD | PMID:14645110 |
| taurine | multiple interactions | ISO | RGD:2053 | 6480464 | Taurine inhibits the reaction [sodium arsenite results in increased cleavage of PARP1 protein] | CTD | PMID:19616567 |
| taurine | multiple interactions | ISO | RGD:2053 | 6480464 | Taurine inhibits the reaction [sodium arsenite results in increased degradation of PARP1 protein] | CTD | PMID:20830294 |
| temozolomide | multiple interactions | EXP | | 6480464 | PARP1 protein affects the susceptibility to [temozolomide co-treated with 2-((R)-2-methylpyrrolidin-2-yl)-1H-benzimidazole-4-carboxamide] | CTD | PMID:19825992 |
| temozolomide | decreases response to substance | ISO | RGD:1551988 | 6480464 | PARP1 protein results in decreased susceptibility to temozolomide | CTD | PMID:21555580 |
| tert-butyl hydroperoxide | multiple interactions | ISO | RGD:1551988 | 6480464 | Catechin inhibits the reaction [tert-Butylhydroperoxide results in increased cleavage of PARP1 protein] | CTD | PMID:16753784 |
| tert-butyl hydroperoxide | increases cleavage | ISO | RGD:2053 | 6480464 | tert-Butylhydroperoxide results in increased cleavage of PARP1 protein | CTD | PMID:15569404 |
| tert-butyl hydroperoxide | multiple interactions | ISO | RGD:2053 | 6480464 | Curcumin inhibits the reaction [tert-Butylhydroperoxide results in increased cleavage of PARP1 protein] | CTD | PMID:15569404 |
| tert-butyl hydroperoxide | increases cleavage | ISO | RGD:1551988 | 6480464 | tert-Butylhydroperoxide results in increased cleavage of PARP1 protein | CTD | PMID:16753784 |
| tetrachloromethane | multiple interactions | ISO | RGD:2053 | 6480464 | [N,N-dimethylformamide co-treated with Carbon Tetrachloride] results in increased cleavage of PARP1 protein; more ... | CTD | PMID:20097184 |
| tetraphene | increases cleavage | EXP | | 6480464 | benz(a)anthracene results in increased cleavage of PARP1 protein | CTD | PMID:21132278 |
| thalidomide | multiple interactions | EXP | | 6480464 | [Curcumin co-treated with Thalidomide] results in increased cleavage of PARP1 protein | CTD | PMID:19372569 |
| thalidomide | increases cleavage | EXP | | 6480464 | Thalidomide analog results in increased cleavage of PARP1 protein | CTD | PMID:15858615 |
| thapsigargin | multiple interactions | EXP | | 6480464 | [orlistat co-treated with Thapsigargin] results in increased cleavage of PARP1 protein | CTD | PMID:17283163 |
| thapsigargin | increases cleavage | ISO | RGD:1551988 | 6480464 | Thapsigargin results in increased cleavage of PARP1 protein | CTD | PMID:20493918 |
| thapsigargin | multiple interactions | ISO | RGD:1551988 | 6480464 | Apigenin inhibits the reaction [Thapsigargin results in increased cleavage of PARP1 protein] | CTD | PMID:20493918 |
| theophylline | affects binding | EXP | | 6480464 | Theophylline binds to PARP1 protein | CTD | PMID:18951874 |
| titanium dioxide | increases expression | EXP | | 6480464 | titanium dioxide results in increased expression of PARP1 mRNA | CTD | PMID:20362650 |
| titanium dioxide | increases cleavage | EXP | | 6480464 | titanium dioxide results in increased cleavage of PARP1 protein | CTD | PMID:20362650 |
| tranexamic acid | multiple interactions | EXP | | 6480464 | Tranexamic Acid inhibits the reaction [Rotenone results in increased cleavage of PARP1 protein] | CTD | PMID:19539006 |
| trans-resveratrol | increases cleavage | EXP | | 6480464 | resveratrol results in increased cleavage of PARP1 protein | CTD | PMID:12690110 more ... |
| trans-resveratrol | increases cleavage | EXP | | 6480464 | resveratrol results in increased cleavage of PARP1 protein | CTD | PMID:12690110 more ... |
| trans-resveratrol | multiple interactions | EXP | | 6480464 | [Coumestrol co-treated with resveratrol] results in increased expression of PARP1 mRNA | CTD | PMID:19167446 |
| trans-resveratrol | increases cleavage | ISO | RGD:1551988 | 6480464 | resveratrol results in increased cleavage of PARP1 protein | CTD | PMID:16675471 more ... |
| trans-resveratrol | increases degradation | EXP | | 6480464 | resveratrol results in increased degradation of PARP1 protein | CTD | PMID:20028382 |
| trans-resveratrol | multiple interactions | EXP | | 6480464 | [resveratrol results in increased activity of CASP3 protein] which results in increased cleavage of PARP1 protein | CTD | PMID:19561642 |
| trans-resveratrol | increases cleavage | EXP | | 6480464 | resveratrol results in increased cleavage of PARP1 protein | CTD | PMID:16617056 more ... |
| trans-resveratrol | increases cleavage | EXP | | 6480464 | resveratrol results in increased cleavage of PARP1 protein | CTD | PMID:16617056 more ... |
| trans-resveratrol | increases cleavage | EXP | | 6480464 | resveratrol results in increased cleavage of PARP1 protein | CTD | PMID:17164350 more ... |
| trans-resveratrol | increases cleavage | EXP | | 6480464 | resveratrol results in increased cleavage of PARP1 protein | CTD | PMID:16814113 more ... |
| trans-resveratrol | increases expression | EXP | | 6480464 | resveratrol results in increased expression of PARP1 protein modified form | CTD | PMID:9680369 |
| trans-resveratrol | increases cleavage | EXP | | 6480464 | resveratrol results in increased cleavage of PARP1 protein | CTD | PMID:19631782 more ... |
| trans-resveratrol | increases cleavage | ISO | RGD:1551988 | 6480464 | resveratrol results in increased cleavage of PARP1 protein | CTD | PMID:16675471 PMID:17872969 |
| trans-resveratrol | increases cleavage | EXP | | 6480464 | resveratrol results in increased cleavage of PARP1 protein | CTD | PMID:17554206 more ... |
| trans-resveratrol | increases cleavage | EXP | | 6480464 | resveratrol results in increased cleavage of PARP1 protein | CTD | PMID:17554206 more ... |
| trans-resveratrol | multiple interactions | EXP | | 6480464 | resveratrol inhibits the reaction [IL1B protein results in increased cleavage of PARP1 protein] | CTD | PMID:17404069 PMID:17959154 |
| trans-resveratrol | increases cleavage | EXP | | 6480464 | resveratrol results in increased cleavage of PARP1 protein | CTD | PMID:16617056 more ... |
| trans-resveratrol | multiple interactions | EXP | | 6480464 | resveratrol promotes the reaction [TNFSF10 protein results in increased cleavage of PARP1 protein] | CTD | PMID:17823925 |
| trans-resveratrol | multiple interactions | EXP | | 6480464 | resveratrol inhibits the reaction [IL1B protein results in increased cleavage of PARP1 protein] | CTD | PMID:17959154 PMID:17404069 |
| trans-resveratrol | multiple interactions | EXP | | 6480464 | [resveratrol co-treated with Paclitaxel] results in increased cleavage of PARP1 protein | CTD | PMID:14749477 |
| trans-resveratrol | multiple interactions | EXP | | 6480464 | resveratrol inhibits the reaction [Dopamine results in increased cleavage of PARP1 protein] | CTD | PMID:17603292 |
| trans-resveratrol | multiple interactions | EXP | | 6480464 | BCL2 protein inhibits the reaction [resveratrol results in increased cleavage of PARP1 protein]; more ... | CTD | PMID:19631782 |
| trans-resveratrol | increases cleavage | ISO | RGD:1551988 | 6480464 | resveratrol results in increased cleavage of PARP1 protein | CTD | PMID:17872969 PMID:16675471 |
| trans-resveratrol | multiple interactions | EXP | | 6480464 | [resveratrol results in increased activity of SIRT1 protein] which results in decreased activity of PARP1 protein | CTD | PMID:16628003 |
| trans-resveratrol | multiple interactions | ISO | RGD:1551988 | 6480464 | resveratrol inhibits the reaction [PPT1 gene mutant form results in increased expression of PARP1 protein modified form] | CTD | PMID:21224254 |
| tricetin | decreases activity | EXP | | 6480464 | tricetin results in decreased activity of PARP1 protein | CTD | PMID:17884996 |
| trichostatin A | multiple interactions | EXP | | 6480464 | [bortezomib co-treated with trichostatin A] results in increased cleavage of and results in increased activity of PARP1 protein | CTD | PMID:16904634 |
| trichostatin A | multiple interactions | EXP | | 6480464 | trichostatin A inhibits the reaction [Benzene results in increased methylation of PARP1 promoter]; more ... | CTD | PMID:20230882 |
| trichostatin A | multiple interactions | EXP | | 6480464 | [trichostatin A results in increased expression of GDF15 protein] which results in increased cleavage of PARP1 protein | CTD | PMID:18801729 |
| trichostatin A | increases degradation | EXP | | 6480464 | trichostatin A results in increased degradation of PARP1 protein | CTD | PMID:16010430 |
| trichostatin A | increases cleavage | EXP | | 6480464 | trichostatin A results in increased cleavage of PARP1 protein | CTD | PMID:17431121 |
| trifluoperazine | multiple interactions | ISO | RGD:2053 | 6480464 | Trifluoperazine inhibits the reaction [Cadmium Chloride results in increased cleavage of PARP1 protein] | CTD | PMID:21544200 |
| trifluoperazine | multiple interactions | EXP | | 6480464 | Trifluoperazine inhibits the reaction [Cadmium Chloride results in increased cleavage of PARP1 protein] | CTD | PMID:21544200 |
| trimellitic anhydride | increases expression | ISO | RGD:1551988 | 6480464 | trimellitic anhydride results in increased expression of PARP1 mRNA | CTD | PMID:19042947 |
| troglitazone | multiple interactions | EXP | | 6480464 | Aspirin promotes the reaction [troglitazone results in increased cleavage of PARP1 protein]; more ... | CTD | PMID:19908241 |
| troglitazone | increases expression | EXP | | 6480464 | troglitazone results in increased expression of PARP1 | CTD | PMID:12680223 |
| troglitazone | increases cleavage | EXP | | 6480464 | troglitazone results in increased cleavage of PARP1 protein | CTD | PMID:19908241 |
| ubiquinones | multiple interactions | EXP | | 6480464 | [Niacin co-treated with Ubiquinone co-treated with Riboflavin] results in increased expression of PARP1 protein | CTD | PMID:18377693 |
| ursodeoxycholic acid | multiple interactions | EXP | | 6480464 | FADD mutant form inhibits the reaction [Ursodeoxycholic Acid results in increased cleavage of PARP1 protein]; more ... | CTD | PMID:21362627 |
| ursodeoxycholic acid | increases cleavage | EXP | | 6480464 | Ursodeoxycholic Acid results in increased cleavage of PARP1 protein | CTD | PMID:21362627 |
| ursodeoxycholic acid | multiple interactions | EXP | | 6480464 | [oxaliplatin co-treated with Ursodeoxycholic Acid] results in increased cleavage of PARP1 protein | CTD | PMID:19728331 |
| ursolic acid | increases cleavage | EXP | | 6480464 | ursolic acid results in increased cleavage of PARP1 protein | CTD | PMID:16012738 |
| valproic acid | multiple interactions | EXP | | 6480464 | [Hydralazine co-treated with Valproic Acid] results in increased expression of PARP1 mRNA | CTD | PMID:17183730 |
| vancomycin | multiple interactions | ISO | RGD:2053 | 6480464 | 1,5-isoquinolinediol inhibits the reaction [Vancomycin results in increased expression of PARP1 protein] | CTD | PMID:19833176 |
| vancomycin | increases expression | ISO | RGD:2053 | 6480464 | Vancomycin results in increased expression of PARP1 protein | CTD | PMID:19833176 |
| verapamil | multiple interactions | ISO | RGD:1551988 | 6480464 | Verapamil inhibits the reaction [PARP1 gene mutant form results in decreased uptake of Doxorubicin] | CTD | PMID:15861398 |
| vincristine | increases response to substance | EXP | | 6480464 | PARP1 gene SNP results in increased susceptibility to Vincristine | CTD | PMID:20864405 |
| wortmannin | multiple interactions | EXP | | 6480464 | wortmannin promotes the reaction [Doxorubicin results in increased cleavage of PARP1 protein]; more ... | CTD | PMID:17935137 |
| wortmannin | multiple interactions | EXP | | 6480464 | wortmannin promotes the reaction [sodium arsenite results in increased degradation of PARP1 protein] | CTD | PMID:12614848 |
| wortmannin | multiple interactions | ISO | RGD:1551988 | 6480464 | wortmannin inhibits the reaction [Cyclosporine results in increased cleavage of PARP1 protein] | CTD | PMID:22155090 |
| ytterbium | increases cleavage | EXP | | 6480464 | Ytterbium analog results in increased cleavage of PARP1 protein | CTD | PMID:19632212 |
| zerumbone | increases cleavage | EXP | | 6480464 | zerumbone results in increased cleavage of PARP1 protein | CTD | PMID:16007145 |
| zinc atom | multiple interactions | ISO | RGD:2053 | 6480464 | 6-hydroxy-2,5,7,8-tetramethylchroman-2-carboxylic acid inhibits the reaction [Zinc results in decreased expression of PARP1 protein]; more ... | CTD | PMID:16799065 |
| zinc atom | multiple interactions | ISO | RGD:1551988 | 6480464 | PARP1 protein affects the reaction [Zinc results in decreased abundance of Adenosine Triphosphate]; more ... | CTD | PMID:17728843 |
| zinc atom | multiple interactions | EXP | | 6480464 | Zinc inhibits the reaction [arsenite results in decreased activity of PARP1 protein] | CTD | PMID:18707137 |
| zinc atom | multiple interactions | EXP | | 6480464 | Zinc inhibits the reaction [monomethylarsonous acid results in decreased activity of PARP1 protein] | CTD | PMID:21925530 |
| zinc atom | increases cleavage | EXP | | 6480464 | Zinc results in increased cleavage of PARP1 protein | CTD | PMID:16472982 PMID:16799065 |
| zinc atom | multiple interactions | EXP | | 6480464 | Cisplatin inhibits the reaction [Zinc binds to PARP1 protein]; more ... | CTD | PMID:21370912 |
| zinc atom | decreases expression | ISO | RGD:2053 | 6480464 | Zinc results in decreased expression of PARP1 protein | CTD | PMID:16799065 |
| zinc atom | increases cleavage | EXP | | 6480464 | Zinc results in increased cleavage of PARP1 protein | CTD | PMID:16799065 PMID:16472982 |
| zinc dichloride | multiple interactions | EXP | | 6480464 | zinc chloride inhibits the reaction [sodium arsenite results in decreased activity of PARP1 protein] | CTD | PMID:19056730 |
| zinc dichloride | increases expression | ISO | RGD:1551988 | 6480464 | zinc chloride results in increased expression of PARP1 protein | CTD | PMID:22253048 |
| zinc dichloride | increases activity | ISO | RGD:1551988 | 6480464 | zinc chloride results in increased activity of PARP1 protein | CTD | PMID:18509044 |
| zinc dichloride | increases response to substance | ISO | RGD:1551988 | 6480464 | PARP1 results in increased susceptibility to zinc chloride | CTD | PMID:18509044 |
| zinc dichloride | multiple interactions | ISO | RGD:1551988 | 6480464 | acetovanillone inhibits the reaction [zinc chloride results in increased activity of PARP1 protein]; more ... | CTD | PMID:18509044 |
| zinc dichloride | multiple interactions | ISO | RGD:1551988 | 6480464 | coomassie Brilliant Blue inhibits the reaction [zinc chloride results in increased expression of PARP1 protein]; more ... | CTD | PMID:22253048 |
| zinc dichloride | multiple interactions | EXP | | 6480464 | zinc chloride inhibits the reaction [cobaltous chloride inhibits the reaction [Doxorubicin results in increased cleavage of PARP1 protein]] | CTD | PMID:19714248 |
| zinc pyrithione | multiple interactions | EXP | | 6480464 | Pentetic Acid inhibits the reaction [zinc pyrithione results in increased activity of PARP1 protein] | CTD | PMID:21424779 |
| zinc pyrithione | increases activity | EXP | | 6480464 | zinc pyrithione results in increased activity of PARP1 protein | CTD | PMID:21424779 |
| zinc sulfate | increases cleavage | EXP | | 6480464 | Zinc Sulfate results in increased cleavage of PARP1 protein | CTD | PMID:16799065 |
| zinc sulfate | decreases expression | ISO | RGD:2053 | 6480464 | Zinc Sulfate results in decreased expression of PARP1 protein | CTD | PMID:16799065 |
| zinc sulfate | multiple interactions | ISO | RGD:2053 | 6480464 | 6-hydroxy-2,5,7,8-tetramethylchroman-2-carboxylic acid inhibits the reaction [Zinc Sulfate results in decreased expression of PARP1 protein]; more ... | CTD | PMID:16799065 |
| zinc(0) | multiple interactions | ISO | RGD:2053 | 6480464 | 6-hydroxy-2,5,7,8-tetramethylchroman-2-carboxylic acid inhibits the reaction [Zinc results in decreased expression of PARP1 protein]; more ... | CTD | PMID:16799065 |
| zinc(0) | multiple interactions | ISO | RGD:1551988 | 6480464 | PARP1 protein affects the reaction [Zinc results in decreased abundance of Adenosine Triphosphate]; more ... | CTD | PMID:17728843 |
| zinc(0) | multiple interactions | EXP | | 6480464 | Zinc inhibits the reaction [arsenite results in decreased activity of PARP1 protein] | CTD | PMID:18707137 |
| zinc(0) | multiple interactions | EXP | | 6480464 | Zinc inhibits the reaction [monomethylarsonous acid results in decreased activity of PARP1 protein] | CTD | PMID:21925530 |
| zinc(0) | increases cleavage | EXP | | 6480464 | Zinc results in increased cleavage of PARP1 protein | CTD | PMID:16472982 PMID:16799065 |
| zinc(0) | increases cleavage | EXP | | 6480464 | Zinc results in increased cleavage of PARP1 protein | CTD | PMID:16799065 PMID:16472982 |
| zinc(0) | decreases expression | ISO | RGD:2053 | 6480464 | Zinc results in decreased expression of PARP1 protein | CTD | PMID:16799065 |
| zinc(0) | multiple interactions | EXP | | 6480464 | Cisplatin inhibits the reaction [Zinc binds to PARP1 protein]; more ... | CTD | PMID:21370912 |
| zoledronic acid | increases cleavage | EXP | | 6480464 | zoledronic acid results in increased cleavage of PARP1 protein | CTD | PMID:10780527 PMID:20977926 |
| zoledronic acid | multiple interactions | EXP | | 6480464 | arsenic trioxide promotes the reaction [zoledronic acid results in increased cleavage of PARP1 protein] | CTD | PMID:20977926 |
| zoledronic acid | increases cleavage | EXP | | 6480464 | zoledronic acid results in increased cleavage of PARP1 protein | CTD | PMID:20977926 PMID:10780527 |